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ABSTRACT

PREDICTORS OF AGITATION IN THE ADULT CRITICALLY ILL
By Ruth Srednicki Burk, PhD
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2013
Director: Mary Jo Grap, Ph.D., RN, FAAN
Nursing Alumni Distinguished Professor
Adult Health and Nursing Systems
School of Nursing

BACKGROUND: Agitation is a common complication in the intensive care unit (ICU)
manifested in behavior and actions that range from simple apprehension or anxiety to frankly
combative behavior.5 Agitation is associated with significant adverse outcomes.1-3 Studies report
up to 71% of ICU patients have some degree of agitation during their ICU stay and that agitation
is observed 32% of the time.3;4 Potential causes of agitation in critically ill patients are
numerous; however, data about factors that predict agitation are limited.
OBJECTIVE: The specific aim of this study was to identify predictors of agitation on admission
to the ICU as well as within 24 hours prior to the first agitation event.
DESIGN: Retrospective medical record review.
SETTING: Two adult critical care units, Medical Respiratory ICU (MRICU) and Surgical Trauma
ICU (STICU) in an urban university medical center.

xi
SUBJECTS: A convenience sample of 200 critically ill adult patients, all older than 18 years of
age, consecutively admitted to a MRICU and STICU, admitted for longer than 24 hours, over a
two month period.
METHODS: Risk factors for agitation were identified from literature review as well as from
expert consultation. Data were collected during the first 5 days of ICU stay. Agitation was
identified using the documented Richmond Agitation-Sedation Scale or notation of “agitation” in
the medical record.
RESULTS: Of the sample 56.5% were male, 51.5% Euro-American, with mean age 55.5 years
(±16.4). Independent predictors of agitation on admission to the ICU were: past medical history
of illicit substance use, height, both the Sequential Organ Failure Assessment respiratory and
central nervous system subscores, and use of restraints. Predictors of agitation within 24 hours
prior to the first agitation event were: percent of hours using restraints, percent of hours using
mechanical ventilation, number of genitourinary catheters, and blood pH and albumin.
CONCLUSIONS: Use of these empirically based data may allow care providers to identify
those at risk as well as predict agitation. Elimination or reduction of agitation in the ICU would
improve patient safety and reduce hospitalization resulting in significant savings to healthcare
costs.

xii
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CHAPTER 1. INTRODUCTION

Care of the critically ill patient in the United States consumes approximately 15% of all
healthcare dollars1 with approximately $80.8 billion spent on intensive care.2 The cost of
complications resulting in an increased intensive care unit (ICU) stay can inflate this amount
significantly. One of the more common complications is agitation. Agitation is most often
described as excessive restlessness, usually non-purposeful physical activity, associated with
internal tension, anxiety, or emotional distress.3-5 In the ICU, agitation can be manifested in
behavior and actions that range from simple apprehension or anxiety, inappropriate self-removal
of indwelling tubes and catheters, attempted assault of a care provider, and to frankly combative
behavior.6 Agitation has been shown to extend the length of stay (LOS) in the hospital7;8 from a
median of 5 to 12 days.7 Studies report up to 71% of ICU patients have some degree of
agitation during their ICU stay9 and that agitation is observed 32% of days.10
The management of agitation usually involves increasing sedative medication or the use
of patient restraints. Medical treatment of agitation may result in excessive sedation and
hemodynamic instability in over 75% of patients,7 seriously compromising patient safety.
Continuous infusion of sedative and analgesic medications is associated with prolonged
mechanical ventilation, organ system failure, increased LOS and reintubation, ultimately
resulting in higher hospitalization costs.11 To avoid these problems, sedative and analgesic
levels are reduced and may result in under-sedation. Attempts to minimize sedative use may
culminate in severe agitation and anxiety with cardiopulmonary instability such as hypertension,
tachycardia, tachypnea, ventilator dysynchrony, hypoxemia and unplanned extubations.12
Sedation of critically ill patients has been shown to result in increased hospital LOS,
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complications of immobility, and hospital costs – with sedative drugs costing more than $500
per day.13
The Joint Commission on Accreditation of Healthcare Organizations (JCAHO) 2000
standards acknowledge that the use of restraints poses an inherent risk to the physical safety
and psychological well-being of the individual and staff, and therefore, is to be used only in an
emergency, when there is an imminent risk of individual harm. These conditions are often
present during agitation. Therefore, early identification and optimal management of agitation will
likely improve patient safety, which is an important target of the national health care agenda.
The Agency for Healthcare Research and Quality (AHRQ), JHACO, and The Centers for
Medicare & Medicaid Services (CMS) support measures to reduce patient physical restraints.
Potential causes of agitation in critically ill patients are numerous; however, data about
factors that predict agitation are limited. The etiology of agitation is multifactoral and agitation is
costly; therefore, management of agitation should be directed at prevention rather than
treatment.
The evaluation of agitation and sedation is primarily a nursing responsibility. Surveys
indicate that nurses are responsible for administering and titrating sedation for patient comfort in
94% of ICUs.14 Currently there is no tool or evaluative system to alert health care providers to
impending agitation, although scales, such as the Richmond Agitation-Sedation Scale15 (RASS),
evaluate degree of agitation once agitation has been identified. Use of empirically based
information would assist care providers to identify those at risk as well as predict agitation.
Identification of patients at particularly high risk for developing agitation provides an opportunity
to implement preventative strategies to protect patients from self- and iatrogenic-induced injury.
Agitation is considered multifactoral – age, gender, severity of illness, past medical
history (PMH)/admitting diagnosis, presence of endotracheal tubes and invasive lines/catheters,
use of sedatives and analgesics, use of restraints, hypoxemia, pain, fever, heart rate (HR), and
blood pressure (BP) are thought to be significant contributing factors.4;5 Chapter 2 summarizes
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a review of the literature of agitation in critical illness – its significance, risk factors, and
evaluation. However, few empirical studies have systematically evaluated predisposing factors.
An exhaustive review by Fraser et al.9 in 2000 found no studies that examined the etiology of
agitation in patients in the ICU. Since then, there have been 4 studies directed at identifying risk
factors.7;8;10;16 Most studies have focused on optimizing sedative therapy and quantifying
agitation rather than addressing prevention.
A retrospective medical record review was initiated to explore the predictors of agitation
in a sample of adult medical and surgical ICU subjects for up to 5 days. This comprehensive
investigation of risk factors is presented in Chapter 3. The purpose of this study was to examine
the relationship of demographic and clinical characteristics of critically ill patients to the
development of agitated behavior. The specific aim of this study was to identify predictors of
agitation on admission to the ICU as well as those present 24 hours prior to agitation.
Data from 200 subjects was collected. Agitation was identified using documentation of
the RASS15 using values of +1 (restless – anxious or apprehensive but movements not
aggressive or vigorous) through +4 (combative – overtly combative or violent; immediate danger
to staff) to identify agitation. The RASS15 is the standard sedation-agitation tool used in both of
the target ICUs and values are routinely obtained every 4 hours and more frequently if needed.
Agitation was also documented using the keyword “agitation” (all forms of the word, “agitated”,
“agitation”, “agit”) recorded from the medical record using physicians’ and nurses’ notes in the
nursing bedside flowsheet, emergency department documentation, operating room notes, and
circle-the-item for reporting agitation in flowsheets.
Risk factors presumed to be associated with agitation, identified from literature review
(Chapter 2) as well as from expert consultation, were used for data collection. Information
pertaining to preadmission risk factors and baseline demographics as well as clinical factors,
theorized and implicated, in the onset of agitation was retrieved from patient medical records.
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Data were summarized by hour, 4-hour block, and day for each subject and categorized
as an agitation or non-agitation hour, block, or day. Documentation of agitation in this manner,
with detail not previously presented in other studies, allowed investigation into the onset,
frequency, and characteristics of agitation. The summary and discussion of these data are
presented in Chapter 3.
Agitation was found in both medical and surgical subjects. Of the 200 subjects, 118
(59%) had at least one episode of agitation during the 5 study days during 319 (31.9%) patientdays. Of the total data hours, the overall agitation rate was 7.8%. The onset of agitation was a
median of 2 hours (range 0-114; IQR 0-13.75) from ICU admission.
On admission, univariate factors associated with agitation were determined. Individual
demographic and preadmission factors present on ICU admission that were significantly
associated with agitation were: male gender, greater body weight, past medical history of illicit
substance use, and psychiatric diagnosis. Agitation was associated with higher severity of
illness including the total Sequential Organ Failure Assessment17 (SOFA) score, the SOFA
respiratory and central nervous system (CNS) subscores, the Glasgow Coma Score (GCS), and
Acute Physiology And Chronic Health Evaluation III18 (APACHE III). Specific clinical factors
associated with agitation were PaO2/FiO2 < 200 mmHg, FiO2, serum pH, serum magnesium,
serum glucose, use of restraints, use of mechanical ventilation (MV), pain rating, number of total
catheters, number of genitourinary (GU) catheters, and number of gastrointestinal (GI) and
other catheters. Following, logistic multivariate regression analysis identified predictors of
agitation on admission as: past medical history of illicit substance use (p=0.0176), height
(p=0.0178), both the SOFA respiratory (p=0.0124) and CNS subscores (p<.0001), and use of
restraints (p=0.0125).
Univariate factors associated with agitation, present 24 hours prior to the first agitation
event, were determined. Significant individual demographic and preadmission factors as well as
severity of illness scores present within 24 hours prior to onset of the first agitation event were

4

the same as the on-admission group. Specific clinical factors prior to the first agitation event
associated with agitation were also the same with the exception of total number of catheters and
GI and other catheters. Logistic multivariate regression identified predictors of agitation within
24 hours preceding agitation to be: past medical history of psychiatric diagnosis (p=0.015),
height (p=0.015), total SOFA score (p=0.012), P/F<200mmHg (p=0.011), serum pH (p=0.026),
percent of hours using restraints (p=0.0003), percent of hours using mechanical ventilation
(p=0.0004), pain rating (0.0059), and presence of genitourinary catheters (p=0.0264).
This study contributes new knowledge to identification of agitation in the medical and
surgical ICU patient populations. This evidence may allow a better understanding of risk factors
of agitation and add to empirical data guiding future research direction. After identification of the
risk factors and predictors of agitation, an evaluative tool can be developed to alert caretakers to
the possibility of agitation, so that interventions can be implemented before agitation occurs.
Elimination or reduction of agitation in the ICU would improve patient safety and reduce
hospitalization resulting in significant improvement in patient health and safety as well as
savings to healthcare costs.
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Abstract
Agitation in critically ill adults is a frequent complication of hospitalization – up to 71% of
intensive care unit (ICU) patients have some degree of agitation during their ICU stay. Agitation
can result in life-threatening complications related to hemodynamic instability, unplanned
extubation and hypoxia, with injury to the patient or care providers, and has been found to
extend the hospital length of stay increasing hospital costs. However, agitation remains
incompletely understood with no gold standards for indicators, assessment approaches,
evaluative tools, or treatment plans. Despite the need for more information in this area, a
consensus has yet to be reached for almost any aspect of agitation. The purpose of this review
is to examine agitation in adult critically ill patients – its significance, risk factors, and evaluation.

9

Care of the critically ill patient in the United States consumes roughly 15% of all healthcare
dollars1 with approximately $80.8 billion spent on intensive care.2 Complications in the intensive
care unit (ICU) can inflate this cost significantly. One of the more common complications is
agitation which can result in a variety of significant and negative patient outcomes and
increased hospital costs. This paper will review the incidence and significance, risk factors,
consequences, and evaluation of agitation as well as present suggestions for directions of future
research.
Agitation is most often described as excessive restlessness, or non-purposeful physical
activity, associated with internal tension, anxiety, or emotional distress.3-5 Patients appear to be
anxious, jittery, and hyperalert. Recently, agitation has also been defined as a nonspecific
constellation of relatively unrelated behaviors that can be seen in a number of different clinical
conditions, usually presenting a fluctuating course.6 These behaviors may include
nonaggressive and aggressive physical components (i.e. pacing, aimless psychomotor activity
vs. fighting, throwing, grabbing) and verbal components (i.e. constant questioning, chatting vs.
cursing, screaming). In the ICU, agitation can be manifested in behaviors and actions that range
from simple apprehension or anxiety, inappropriate self-removal of indwelling tubes and
catheters, attempted assault of a care provider, and to frankly combative behavior.7;8 There
appears to be a growing consensus that agitation exists on a continuum from jitteriness and
fidgeting with little or no confusion to overt combativeness with or without delirium.9 Observed
and postulated physiologic manifestations of agitation seen in escalating movement include
increased sympathetic nervous system tone as well as increased levels of circulating
catecholamines, resulting in palpitations, tachycardia, arrhythmias, increased blood pressure,
vasoconstriction of the extremities, myocardial ischemia, infarction and sudden death.6;10;11
Agitation has been shown to be associated with longer length of stay in the hospital12;13 from
(a median of) 5 to 12 days.12 Studies report up to 71% of ICU patients have some degree of
agitation during their ICU stay14 and that agitation has been observed in up to 32% of patient-
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days.15 In a prospective evaluation of adult medical ICU patients by Carrion et al.,16 moderate
or severe agitation was observed by bedside nurses in over 20% of patient-shifts, and overt
agitation, such as resulting in self-removal of a tube or catheter or aggressive behavior towards
a healthcare provider, in 9% of patient-shifts.
Agitation treatment usually involves the increased use of sedation or restraints; however,
both have inherent problems. Continuous infusion of sedative and analgesic medications is
associated with prolonged mechanical ventilation (MV), organ system failure, and increased
length of stay and reintubation, ultimately resulting in higher hospitalization costs.17 Medical
treatment of agitation may result in excessive sedation and hemodynamic instability, impacting
over 75% of patients in one study,12 and potentially seriously compromising patient safety. To
avoid these problems, doses of sedative and analgesic medication may be reduced or infusions
temporarily stopped – which can then result in under-sedation. Attempts to minimize sedative
use may culminate in severe agitation and anxiety with cardiopulmonary instability such as
hypertension, tachycardia, tachypnea, and unplanned extubations.18
Risk Factors for Agitation
Agitation is poorly understood with no identified gold-standard for indicators, assessment
approaches or treatment plans. Few empirical studies have systematically evaluated
predisposing risk factors in the ICU environment, although agitation has been identified for over
100 years; reports of observed agitation were present in the early days of ICUs.19 Thus far,
most research has focused on optimizing sedative therapy.
Experts have unanimously theorized that agitation is the result of intrinsic and/or extrinsic
factors producing psychological and/or physical stress (Table 1); however, to date, studies have
been inconclusive of specifically which factors, or combinations of factors, are involved in
agitation. Although critically ill patients suffer both psychological and biological stressors, and
these are present and implicated in virtually all cases of agitation, it is not yet understood why
some critically ill patients never experience agitation.3-5
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Agitation is also thought to be a result of dysregulation of neurotransmitters. Sachdev and
Kruk20 proposed a model of restlessness in different clinical disorders involving disturbances of
the cortico-striatal-thalamic circuits of the brain, explained by increased or decreased levels of
dopamine, serotonin, gamma-aminobutyric acid (GABA) and noradrenergic activity.6;21
An exhaustive review by Fraser et al.14 in 2000 found no studies in the previous 30 years
with a primary goal to evaluate risk factors for agitation in ICU patients. Their search included a
variety of databases: Health Periodicals Database, Cancerlit, Internet, Cinahl, Health
Periodicals, MEDLINE, and Psych Info. Since that time only 4 studies have been found to be
published.12-15 (Table 2). It is important to recognize that publication bias in these literature
searches may exist in that non-significant or negative results may not have been published.
The four studies addressed the etiology of agitation from the context of gaining information for
specific populations – the elderly, mechanically ventilated patients, Medical Respiratory ICU
(MRICU) patients, and a general mixed medical-surgical ICU population.
Risk factors for agitation are categorized into four groups: patient characteristics, ICU
therapies, critical illness, and physiologic instability. The empirical data from these 4 recent
studies is reviewed here. While these studies have shown some agreement in risk factors, there
are also conflicting results.
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Table 1. Factors proposed to be involved in the onset of agitation
Physiologic

Environmental

Technological

Pharmacologic

Patient Characteristics

Severity of illness

Noise

Mechanical ventilation

Sedatives

Age

CNS insults

Lack of windows

Restraints

Analgesics

Sex

Dyspnea

Visitation policies

ET/NG/Trach tubes

Anticholinergics

PMH

Nausea

Temperature

Foley catheters

Paralytics

Psychiatric history

Constipation

Light intensity/source

Feeding tubes

Anesthetics

Drug abuse

Thirst

Odors

PA, CV & other arterial lines

Steroids

Alcohol abuse

Organ failure

Radiological tests

Bronchodilators

Allergies

Patient-ventilator dyssynchrony

Laboratory work

Cardiac drugs

Family history/genetics

Fever

Dialysis

Antihistamines

Anxiety/stress

Hypoxemia

Bedside monitors

Antibiotics

Diagnostic tools

Drug-drug interactions

Hemodynamic monitoring devices

Antipsychotics

CNS – Central Nervous System
ET – Endotracheal
NG – Nasogastric
Trach - Tracheal
PA – Pulmonary Artery
CV – Central Vein
PMH – Past Medical History
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Table 2. Empirical studies of factors associated with agitation
Study

Sample, Design and
Objective

Inclusion criteria Agitation evaluation

Factors found associated with agitation

Fraser, et al.,
2000, USA

130 patients;
Multidisciplinary ICU
(Tertiary care center)
Prospective observational
design:
to study the frequency,
duration, severity, and
treatment of agitation in ICU
patients to determine if the
elderly represent a distinct
population

All patients older
than 18 admitted
for longer than 24
hours, for a 4
month period

SAS; agitation defined as SAS
greater than 4

Anxiety, delirium, drug administration, and
pain. 97% of instances of severe agitation
were associated with several possible
etiologies.

Woods, J.C.,
et al., 2004,
USA

143 patients; Medical ICU
(Tertiary care center),
Prospective observational
design:
to determine the frequency,
characteristics and
outcomes of severe agitation
among ventilated ICU
patients

All MV patients,
18 or older,
admitted for
longer than 24
hours, for a 4
month period

Severely agitated patients were: younger,
more likely to be admitted from an outside
hospital ICU, had lower pH, and a
PaO2/FIO2 less than 200 mmHg.

Jaber, S., et
al., 2005,
France

182 patients; Medicalsurgical ICU; Prospective
observational design:
to evaluate the incidence,
risk factors, and outcomes of
agitation

All patients

MAAS; only evaluated severe
agitation (2 or more MAAS scores
higher than 4 in a 24 hr period and
sedative and/or analgesic agents
higher than recommended
guideline dosages OR the
combination of two sedatives
within the same 24 hr period,
because maximal doses of one
sedative did not achieve adequate
sedation)
Modified Ramsay scale; agitation
defined as a modified Ramsay
score of 1
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Sepsis, alcohol abuse, use of sedatives,
fever, dysnatremia, and use of
psychoactive drugs

Gardner, K.,
Sessler, C.N.,
Grap, M.J.,
2006, USA

83 patients; Medical
Respiratory ICU;
Retrospective chart review:
to examine the relationship
of clinical, laboratory, and
intervention characteristics
of ICU patients to agitation

Patients 18 yo or
older, admitted
over a one-month
period

RASS; agitation defined as a
RASS score of 2 or higher

ICU – Intensive care unit
MV – mechanically ventilated
SAS – Sedation Agitation Scale
MAAS - Motor Activity Assessment Scale
RASS - Richmond Agitation-Sedation Scale
APACHE II - Acute Physiology, Age, Chronic Health Evaluation II
MODS - Multi-Organ Dysfunction Scores
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Higher APACHE II scores, daily MODS
scores – among the MODS subscores,
specifically the pulmonary, cardiovascular,
and neurologic components were higher in
agitated patients

Patient Characteristics. Individual patient characteristics such as demographics, medical
history, and admitting status may provide susceptibility to agitation.
Demographics, specifically age and gender, have been thought to be associated with
agitation. All studies evaluated the relationship between age and agitation with some
inconsistency in the data. No relationship was found between presence of agitation and age in
three of the studies13-15 and it should be noted that the objective of the one by Fraser et al.14
specifically addressed this possibility. In 2000, Fraser et al.14 compared agitation in young
versus elderly patients related to frequency, severity, onset, and duration, and the choice and
route of sedating agent(s), dosing requirements, and adverse effects. This prospective medical
record review involved 130 patients older than 18 years of age admitted for longer than 24
hours during a 4-month period. Of the 130 patients, 92 (70.8%) were described as having
agitation. Severity of illness was measured using the admission Acute Physiology and Chronic
Health Exam (APACHE) II score.22 Agitation, measured by the Riker Sedation-Agitation Scale7
(SAS) as a score greater than 4, derived from written descriptions of behaviors in patient
documentation, was linked with suspected causes by identifying potential etiologies in medical
records. If a caregiver assigned a cause of agitation, it was classified as a probable cause; if
none was assigned, all factors present during agitation were classified as possible causes.
Additional data collected included laboratory values indicating hepatic or renal dysfunction, need
for ventilatory support, and ICU admission information. Analysis involved descriptive statistics
and univariate analyses followed by simple regression to determine the association between
ICU length of stay and severity of agitation using alpha=0.05 as the level of significance. The
study described factors found in the agitated patient, but did not identify predictors of agitation.
Although they found no relationship between agitation and age, they did find that the elderly
experienced a higher frequency of side effects (55%) than younger patients (33%).
Woods et al.12 in 2004 studied the frequency, characteristics, and outcomes of severe
agitation in mechanically ventilated (MV) medical ICU patients with a prospective medical record
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review. Of the 143 enrolled patients, 23 (16.1%) exhibited severe agitation. The study lasted
approximately 4 months with a patient length of stay in the ICU for a minimum of 24 hours. The
main outcome variable, severe agitation, was defined as two or more Motor Activity Assessment
Scale (MAAS) scores above 4 in a 24-hour period, and sedative and/or narcotic doses above
the established sedation and analgesia protocol, or a combination of two or more sedatives
because adequate sedation was not initially achieved. The MAAS was assessed by nursing
staff; daily interruption of sedation was not practiced. Data collected included admission
information, a severity of illness (APACHE II) score,22 arterial blood gases with corresponding
ventilator settings, laboratory values, nursing interventions, total doses of sedatives, analgesics
or neuromuscular blocking agents as well as documented new conditions or adverse events,
discharge disposition, length of stay, weaning status, and patient instigated removal of
endotracheal (ET) tubes, nasogastric (NG) tubes, or arterial lines. Analysis involved descriptive
statistics and time-to-event using Cox-proportional hazards with time-varying covariates
comparing the two groups (severely agitated and non-agitated patients); resulting estimates
were reported as hazard ratios (95% confidence interval [CI]). The study focused on
characteristics and outcomes of severe agitation rather than on factors that may predict earlier
levels of agitated behavior. Surprisingly, in this study, one of the four factors in their multivariate
analysis found to be correlated to severe agitation in MV patients was younger age (50.2 versus
62.6 years, p=0.0016). The authors stated that the differences found may be related to: 1)
differences in inclusion criteria as only severely agitated patients were studied; 2) the use of an
ICU protocol to manage sedative and/or analgesic agents based on the most recent practice
guidelines; and 3) relative ratio differences – a lower rate of agitation in patients older than 65
may have made it appear that younger patients had a higher rate.
Jaber et al.,13 in 2005, used a prospective observational design in a study over 8 months, to
evaluate the incidence, risk factors, and outcomes of agitation in 182 medical-surgical ICU
patients, both receiving, and not receiving, mechanical ventilation. Agitation was identified in 95
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(52%) of the 182 patients. Agitation was assessed daily by a clinical pharmacist using a
modified Ramsay score (agitation designated as a score of 1) as well as by use of recorded
notes from care providers. The evaluation was then confirmed during a daily meeting of ICU
physicians and nurses. Data collected included admission and discharge information, severity
of illness score (Simplified Acute Physiology Score [SAPS] II)23, and history of psychoactive
drug use or ethanol abuse, characteristics of agitation, laboratory values, temperature, and
presence of sepsis. Descriptive statistics were used followed by univariate analysis between
the two groups (agitated and nonagitated patients). These univariate predictors were then used
to model the risk of agitation by using stepwise block regression. The Hosmer and Lemeshow
test was used to determine appropriateness of the model (p=0.053). A p<0.05 was considered
significant. They found no relationship between age and agitation.
A study in 2006 conducted by Gardner, Sessler and Grap15 used a retrospective chart
review of 83 subjects over a 2-month period in a Medical Respiratory ICU. Data obtained from
this study is limited to a published abstract. Of the 83 patients, 35 (42%) were agitated during at
least one day of their ICU stay. Since routine agitation-sedation scoring was not conducted in
this unit during the study period, nursing documentation was used to rate the level of agitation.
Data collected included admission information, severity of illness (APACHE II22) score, daily
multi-organ dysfunction scores (MODS), frequency of agitated behavior, and number of tubes
and lines pulled. No association between age and agitation was found.
Empirical evidence suggesting a lack of relationship between age and agitation, although
not conclusive, is compelling. Comparison of the 4 studies is difficult due to Woods et al.’s12
narrow spectrum of both population (exclusively MV) and agitation level (specifically severe
agitation), while the others used more general criteria. Jaber et al.13 also commented that the
limitations of statistical analysis needs to be considered as the number of severely agitated
patients was small (n=23). With respect to an association between gender and agitation,
empirical evidence suggests no relationship – all four studies reported no correlation.
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Medical history, including alcohol or drug use/abuse, use of antipsychotic medications for
treatment of psychiatric disorders, admitting diagnosis, and admission from an outside hospital
were studied to determine association with agitation. Alcohol use/abuse as a risk factor for
agitation was examined in 3 of the studies and an association was found in 1. In 95 agitated
general ICU patients, Jaber et al.13 found history of alcohol use/abuse (n=40 vs 15, p=0.001;
odds ratio 3.32, 95% CI [1.12-10.0]) to be one of 7 independent risk factors for agitation. Of the
study participants, 30% had a history of alcohol abuse as defined by a frequency of >14 U
(units)/week and/or periods of time with >4 U/day. In their study, those with a history of alcohol
abuse were three times more likely to become agitated than those who were not. In contrast,
both Woods et al.12 (severe agitation and MV patients) and Gardner et al.,15 with agitated
patients of n=23 and n=35 respectively, found no such relationship. Criteria for determining
alcohol dependency or alcohol use was not defined so a comparison of these 2 studies to Jaber
et al.’s13 may be difficult. Also limitations of statistical analyses for small sample sizes should be
considered. Thus, empirical evidence is inconclusive with respect to alcohol use/abuse. In the
analysis of drug use, 2 studies12;15 addressed the possible predictor; neither finding a significant
relationship in the multivariate analysis. In the univariate analysis marijuana use (Hazard ratio
7.94, 95% CI [1.82-34.73], p=0.007) was significantly associated with the development of
severe agitation in 23 MV agitated patients.12 Neither study described the criteria for
determining drug use or types of drugs considered. Considering the limitations of both sample
size and narrow limits of population and agitation, empirical evidence is inconclusive regarding
the relationship between drug use and agitation. Psychoactive drug use (in the context of
regular antipsychotic medications for treatment of a psychiatric disorder) was examined by
Jaber et al.13 in 182 patients (21% used psychoactive drugs before hospitalization), and was
found to be a risk factor of agitation in their multivariate model (n=32 vs 6, p=0.001).
Additionally, patients who regularly used psychoactive drugs were 5 times more likely to
develop agitation than those who did not. The types of drugs were not discussed. The authors
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commented that the significant relationship may be explained by the characteristics of the study
population who were frequent users of psychoactive drugs. Empirical evidence for this factor is
inconclusive. Admission status, both admitting diagnoses and origin of admission, were
examined in relation to agitation. Admitting diagnosis was examined and was not found to be
significant factor in multivariate analyses. Woods et al.12 and Gardner et al.15 gathered
diagnoses present on admission. Jaber et al.13 recorded reason for ICU admission for the two
distinct populations – surgical and medical patients. In the univariate analysis they found that
the incidence of agitation was greater in the medical patients than among the surgical patients
(38 of 46 patients, 83%; vs 57 of 136 patients, 42%; p<0.001). With respect to origin of
admission, admission from an outside hospital was found to be significantly associated (48%
versus 21%; p=0.0158) in the multivariate analysis by Woods et al.12 The authors commented
that there was a possibility that the transferred patients were sicker than those admitted inhouse, although APACHE II scores did not reflect this. They argued that post-admission
developments may not have been reflected in the admission APACHE II ratings, supported by a
study that found patients transferred to a tertiary center ICU have a longer hospital stay and
higher mortality compared with those admitted directly to an ICU.24 They also stated that it was
unknown to what extent sedation and analgesia protocols were utilized by referring hospitals.
The limited sample size and narrow limits of both the population and agitation definition call into
question the strength of this association. Empirical evidence is inconclusive with respect to a
relationship between admission status and agitation.
ICU Therapies. Treatment of the critically ill patient involves regimens employing the
use of invasive lines and pharmacotherapeutics possibly associated with agitation.
Endotracheal (ET) tube intubation has been found to be a source of stress and irritation to the
critically ill patient25-27 and, therefore, suspected of contributing to agitation. Two studies12;13
examined this relationship and found mechanical ventilation to have no relationship to agitation.
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One study13 found a univariate but no multivariate association in the incidence of agitation in
those with and without MV.
Critically ill patients receive numerous pharmacotherapeutics. Multiple drugs, with
appropriate as well as unintended under- and over-medication, may result in significant and
unpredictable interactions, and is thought to be one of the more common causes of agitation
(Table 3). These therapies can act, and interact, unpredictably. The pharmacological treatment
itself may not be associated with agitation; however, the numerous metabolites and their varying
elimination rates may contribute to or precipitate agitation. Psychological stress to the patient
associated with undersedation and the inadequate treatment of discomfort and pain, as well as
physiological stress associated with the critical illness and its pharmaceutic treatment have
been thought to be related to the onset of agitation. In particular sedatives, especially the
benzodiazepines, most frequently used to treat agitation, and analgesics, specifically opiates,
have been studied with relation to agitation.
Woods et al.12 measured the daily total dose of sedatives, analgesics or neuromuscular
blocking agents and found that both sedatives and analgesics were administered to MV patients
experiencing severe agitation more frequently and in greater doses both prior to, or on the day
of, agitation onset as well as throughout the ICU stay. Specifically, 96% of severely agitated MV
patients received lorazepam at some point during their medical ICU (MICU) stay compared to
75% of those who were non-agitated (p=0.028); midazolam was reported as 70% vs. 39%
(p=0.007); propofol was reported as 83% vs. 32% (p<0.0001); continuous IV morphine as 61%
vs 18% (p<0.001), total morphine as 83% vs. 59% (p=0.033); and fentanyl as 61% vs 38%
(p=0.037). Similarly, Jaber et al.13 found that use of sedatives was an independent risk factor
for agitation (Odds Ratio 4.03, 95% CI [1.62-10.4]). In the univariate analysis a significant
association with agitation was found with benzodiazepines (54 of 74 patients, 73%, p=0.001),
opioids (46 of 64 patients, 72%, p=0.001), and neuroleptic drugs (17 of 19 patients, 89%,
p=0.001); however, in the multivariate analysis there was no increase in agitation based on
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these specific classes as well as others (propofol, clonidine). They found that the general use of
sedatives and/or analgesics in the 48 hours preceding the onset of agitation is more frequent in
agitated patients than in patients who are not (72% vs. 36%, p=0.001). They also found that the
use of sedatives and/or analgesics increased the risk of agitation by approximately four times.
Data regarding specific drugs was not discussed. Fraser et al.,14 (n=130) in the comparison of
young vs. older patients, evaluated sedating medications as defined as benzodiazepines
(lorazepam, midazolam), butyrophenones (haloperidol), and barbiturates (phenobarbital) with
respect to treatment of agitation. Drugs, dosages, and routes of administration were examined
and they found agitated patient-days associated with administration of opiates (72%),
benzodiazepines (62%), and haloperidol (29%).14 The study also reported that drug
administration (as well as pain, anxiety, and delirium) accounted for 73% of probable or possible
factors attributed to the onset of agitation – but all of these factors were assigned by caregiver
judgment, not derived empirically.
It is not surprising that sedatives are associated with agitation – as sedatives are the primary
therapy for agitation; however, the increased use of sedatives prior to the onset of agitation
raises questions about the involvement of other mechanisms, processes, or paths. Confounding
this possible involvement is the simple understanding that healthcare providers, observing
restlessness and anxiety and/or a worsening condition, may choose to administer or increase
sedatives as a measure to increase patient comfort. As these four studies did not measure
anxiety or restlessness as an indication of impending agitation, the increase in medication
observed prior to agitation may simply be due to a caregiver response to observed behavior.
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Table 3. Medications thought to be associated with agitation or delirium in the Intensive
Care Unit4;31
Antibiotics

Cardiac Drugs

Acyclovir

Captopril

Amphotericin B

Clonidine

Cephalosporins

Digoxin

Ciprofloxacin

Dopamine

Imipenem – cilastin

Labetalol

Ketoconazole

Lidocaine

Metronidazole

Nifedipine

Penicillin

Nitroprusside

Rifampin

Procainamide

Trimethoprim - sulfamethoxazole

Propranolol
Quinidine sulfate

Anticonvulsants

Corticosteroids

Phenobarbital

Dexamethasone

Phenytoin

Methylprednisolone

Miscellaneous Drugs

Narcotic Analgesics

Hydroxyzine

Codeine

Ketamine

Meperidine

Metroclopramide

Morphine sulfate

Theophylline
Anticholinergics
Benzodiazepines
Nonsteroidal anti-inflammatory agents
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Critical Illness. Illness severity and the presence of pain have been studied with
relationship to agitation in the critically ill patient. Higher severity of illness ratings, reflecting a
higher degree of physiological stress, is thought to be related to the onset of agitation as most
scoring schemas reflect derangements of different body systems. Jaber et al.13 (n=182) studied
severity of illness with association to agitation and found that patients with agitation had a higher
Simplified Acute Physiology Score (SAPS) II score (40 ± 16 vs 33 ± 13, p<0.01) on admission
than those who did not. The SAPS II tool provides an estimate of the risk of death based on
daily physiologic variables rather than on medical history or diagnosis. Significant findings of the
Gardner et al.15 study were that patients with greater levels of illness at admission and during
the ICU stay appear to have a greater risk for developing agitation. In their retrospective chart
review (n=83) they found that the Acute Physiology And Chronic Health Evaluation (APACHE) II
scores, a severity of disease classification system on admission, was significantly greater (23.8
vs 17.5; p=0.002) in those subjects who experienced agitation during their ICU stay compared
to those who did not. They also found daily multi-organ dysfunction scores (MODS) were also
higher (8.2 vs 6.8, p=0.002) on days when subjects were noted to exhibit agitated behavior. In
contrast, Woods et al.12 (n=143) reported no significant difference in APACHE II scores in the
study of severely agitated MV patients. Jaber et al.13 found agitation associated with a
prolonged ICU stay (16 ± 19 days vs. 6 ± 6 days, p=0.0001) while Woods et al.12 found severe
agitation in MV patients to be associated with longer MICU stays (median of 12 vs. 5 days,
p<0.0001). It would be difficult to determine if the severity of illness or agitation was primarily
responsible for the prolonged ICU stay. It is also important to note that complex relationships
exist between organ dysfunction, severity of illness, and interventions confounding the
determination of agitation risk.
Pain has long been theoretically associated with agitation3;4 because higher pain ratings
may reflect a higher degree of both physiological and psychological stress; however, no studies
have reported empirical data supporting the proposition. In the prospective chart review by
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Fraser et al.14 (n=130), pain (with anxiety, delirium, and drug administration) accounted for 73%
of probable or possible factors attributed to the onset of agitation as determined by written
report of caregivers. It is not clear whether presence of pain was assigned by caregiver
judgment or patient report.
Physiologic instability. Physiological alterations have been identified as risk factors for
agitation (Table 4). Dysregulated physiologic systems, as evidenced by disturbances of
oxygenation and electrolyte values, diagnoses of sepsis, and physical manifestations of critical
illness, such as fever, have been implicated in the onset of agitation4;28;29 as all reflect
physiological stress.
Hypoxia is commonly associated with agitation. Lowered blood oxygen content stimulates
the sympathetic nervous system to release catecholamines with resulting muscle tension and
anxiety. Inadequate oxygenation from restricted lung expansion, mechanical ventilator
dysynchrony, and disease process may contribute to oxygen saturations below 90% leading to
agitation. Woods et al.12 (n=143) in their study of severely agitated MV patients (n=23) found a
PaO2/FIO2 below 200 mmHg to be an independent risk factor for severe agitation (Hazard ratio
1.61, 95% CI [1.02 – 2.54], p=0.041). In their univariate analysis an increased FiO2
(presumably in response to a low PaO2 but not discussed) was a factor associated with severe
agitation.
Electrolyte imbalances have been implicated in the onset of agitation. Jaber et al.13 (n=182)
collected daily documented serum concentration of sodium, potassium, magnesium (as well as
urea, creatinine, calcium and phosphorus) to examine the relationship to agitation. In their
univariate analysis an association was found with highest sodium (median: 143.0 [140.0-143.0
(25th-75th percentile)] vs. 139.0 [137.0-142.0], p=0.001) and lowest sodium (median: 132.5
[130.0-135.0] vs. 134.5 [131.2-137.0], p=0.016), lowest potassium (median: 3.28 [3.00-3.63] vs.
3.53 [3.20-3.89], p<0.001), and highest magnesium (median: 1.10 [1.00-1.30] vs. 1.05 [0.901.20], p<0.01). In the final multivariate analysis they determined dysnatremia (sodium level ≤
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134 mmol/L or ≥ 143 mmol/L) to be an independent risk factor for agitation (Odds ratio 2.61,
95% CI [1.03-6.58]). Studying pH, Woods et al.12 (n=143) with MV severely agitated patients
(n=23), also collected daily laboratory values and identified a lower pH (minus 0.1 unit) to be a
factor associated with severe agitation (Hazard ratio 1.55, 95% CI [1.05-2.31, p= 0.028). The
authors commented that the worse acidemia may reflect a greater degree of illness or having
received high-dose intravenous lorazepam which can cause hyperosmolar anion gap metabolic
acidosis mediated by the large volumes of infused propylene glycol as the carrier molecule for
lorazepam.
Sepsis is believed to stress physiological systems and is considered to be associated with
agitation. Due to both bacterial load and toxins, sepsis may result in hypotension leading to
inadequate oxygenation – an additional stressor. Sepsis disrupts microvascular blood flow and
oxygen delivery causing a decrease in tissue oxygen extraction. Jaber et al.13 found that sepsis
was an independent risk factor for the development of agitation (Odds ratio 2.61, 95% CI: 1.036.58). The onset of fever is an indication of the body’s immune response to infections and
inflammation triggered by viruses, bacteria, fungi, drugs, and toxins. These substances and
many others are known to be indicative of physiological stress and are thought to precede
agitation but only one study supported the association empirically. Jaber et al.13 used the
definition of sepsis according to the criteria of Bone30 and found body temperature greater than
or equal to 38 degrees (100.4o C) to be an independent risk factor for agitation (Odds ratio 4.52,
95% CI: 1.80-11.49).
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TABLE 4. Physiological alterations proposed to be associated with agitation or delirium4;28;29
Acidosis

CNS infection

Tension pneumothorax

Hypoxemia

Cerebral abscess

Intoxication

Hypercarbia

Intracranial hemorrhage

Withdrawal

Electrolyte imbalance

Epidural or subdural hematoma

Myocardial ischemia

Sepsis

Meningitis

Intestinal ischemia

Hypoglycemia

Encephalitis

Cerebral ischemia

Hyperglycemia

Liver encephalopathy

Iatrogenic complications

Tumor

Uremic encephalopathy

Elevated heavy metals –
lead, mercury, and manganese
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Consequences of Agitation
Agitation is not a benign condition and has serious consequences largely related to sedation
and restraint use. Eighty-five percent of adult ICU patients receive intravenous (IV)
sedation5;31;32 to ameliorate fear and anxiety, facilitate sleep, and increase tolerance of tubes,
lines, and catheters. The goals of sedative use in the critical care setting are to provide
physiologic stability and patient comfort; however, with the onset of agitation, patients may
experience over-sedation and/or restraints. Historically, at the onset of observed agitation, due
to danger to caregivers and patients, both physical restraints and/or increased sedation
(pharmacologic restraint) was used. Outcomes of the use of restraints, both pharmacologic and
physical, have been shown to be similar and significant – increased danger to patients.33;34 In
recent years, deep or prolonged sedation has been shown to prolong the duration and weaning
of MV.17;35 Lighter and more limited sedation practices with a goal of calm and alert or easily
aroused patient state is the present focus to minimize the consequences of prolonged MV.35-37
Over- and Under-sedation.
Over-sedation. Over-sedation can result in increased length of time of mechanical
ventilation, coma, respiratory depression, hypotension, bradycardia, ileus, renal failure,
immunosuppression, and post-traumatic stress syndrome (PTSD)17;38;38-41 which may include
complications of continuous IV sedation including increased length of intensive care stay and
hospital stay, acquired organ system derangements, and increased frequency of reintubation.17
Extended sedation also has been implicated in increased risks for complications of
immobility, such as deep venous thrombosis, decubitus skin ulceration, and pressure-induced
peripheral neuropathy.42-47 Over-sedation also adds to the cost of hospitalization from extended
length of stay, sedative expense, and mechanical ventilation.48 Dasta et al.49 studied daily ICU
cost in 2002 dollars of both MV and non-MV patients. They found average daily ICU costs to be
$19,725 (25th percentile $5,613; 75th percentile $21,420). They also estimated a nonmechanical ventilation day today to be $2,880 (95% CI $1,219 - $4,541) in contrast to a
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mechanical ventilation day of $5,811 (95% CI $5,050 - $11,374). Each additional day of
mechanical ventilation cost approximately $5,700 and mechanical ventilation was found to be
the greatest independent predictor of cost (p< 0.0001).
The American College of Critical Care Medicine of the Society of Critical Care
Medicine’s (SCCM) guidelines for the sustained use of sedatives and analgesics in the critically
ill adult recommend that sedatives be administered to a defined endpoint with systematic
tapering of the dose or daily interruption with retitration to minimize prolonged sedative effects.
Although optimal sedative levels are the goal, under-sedation may also occur.
Under-sedation. Under-sedation or inadequate sedation increases the risk of developing
anxiety and/or agitation which may lead to serious consequences.12 Inadequate levels of
sedation may place the intubated patient at risk for self-extubation (SE) or removal of
therapeutic lines, physical harm or injury due to an agitated state,12;50 disruption of ICU therapy,
and PTSD. Under-sedation and/or agitation can also affect caregiver workloads. In managing
an agitated patient, the caregiver’s attention can be consumed by one patient, limiting time for
other patients or responsibilities.
Care of the critically ill patient often includes the use of numerous indwelling tubes and
vascular catheters that may be a source of patient stress and irritation. Their removal by the
confused, agitated patient is common and can be life-threatening.4 Several authors have
documented that agitated patients are more likely to remove indwelling tubes or catheters and
the incidence was shown to range from 20% to 28%.18;51 SE of endotracheal tubes occurs
much more frequently in agitated patients.12;52 In a study of unplanned extubations in 426
mechanically ventilated adult patients over a 2-month period, Boulain18 found that 61% were
agitated at the moment of an unplanned extubation. Over a one month period, Fraser et al.53
found a frequency of patient-initiated device removal of 28% and, significantly, agitation was
documented within 2 hours of 74% of the events. Mion et al.54 studied 49,482 patient-days in 49
randomly selected adult ICUs and found that patients removed 1623 devices on 1097 occasions
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for an overall rate of 22.1 episodes/1000 patient-days (range 0-102.4). More than half (58%)
the patients had documented agitation or anxiety at the time of the episode.
Significant adverse events following SE occur in up to 28% of ventilated patients including
bronchospasm, vocal cord damage, and onset of new arrhythmias.55-57 SE has also been
shown to increase ICU and hospital length of stay, duration of MV, and rate of ICU-acquired
infections.58 In addition mortality was found to be higher among patients with unplanned
extubation that required reintubation than among those that did not require reintubation.58
Krinsley and Barone58 examined 100 patients over a period of 5 months finding 44 instances of
unplanned extubation that required reintubation.
There is also significant cost associated with unplanned device removal, which is often
associated with agitation. Fraser et al.53 investigated the frequency and cost of patient-initiated
device removal in the ICU. Patients who removed devices had a longer ICU stay – 11.4 vs. 4.7
days – adding to hospitalization expense. Costs associated with device removal in 2001 were
estimated to be $7606, and the estimated annual cost was approximately $250,000. Using a
conservative estimate of inflation, the cost per episode today would be approximately $10,000,
and the estimated annual cost would be approximately $336,000. In a study of unplanned
extubations in a surgical ICU by Curry et al.59 it was reported that the hospital indirectly
calculated (from limited data) the cost of intubation of $1000 per reintubation event. The
authors state that this estimate could be conservative compared to other hospitals’ costs.
Agitation as a result of under-sedation may also result in disruption of treatment regimen
as Woods et al.12 found that 30% of agitated patients versus 8% of non-agitated patients
experienced disruption of therapy. Disruption of treatment regimen may lead to poorer
outcomes, increased length of stay and higher costs.
Inadequate sedation and analgesia during neuromuscular blockade has been shown to
be associated with PTSD.60;61 Patients report vivid recall under paralysis which may contribute
to PTSD symptoms.
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There are also problems associated with daily sedative interruption to minimize
prolonged sedative effects. Kress et al.62 found that sedative interruption was associated with
significant changes in vital signs – heart rate, blood pressure, rate-pressure product, and
respiratory rate all increased significantly. Concomitant with these changes in vital signs,
epinephrine, norepinephrine, and dopamine levels were markedly increased in a subgroup of
patients not receiving exogenous vasoactive drugs.
Restraint use in agitation.
In brief, the Joint Commission on Accreditation of Healthcare Organizations 2000 standards
acknowledge that the use of restraint poses an inherent risk to the physical safety and
psychological well-being of the individual and staff, and are to be used only in an emergency,
when there is an imminent risk of individual harm.63 These conditions are often present during
agitation. Therefore, early identification and optimal management of agitation will likely improve
patient safety, part of the national health care agenda.63;64;65 However, use of physical restraints
for agitated patients may be necessary to protect both the patient and staff. Harmful
consequences may occur, either directly or indirectly, as a result of the use of physical restraints
including new onset of bladder and bowel incontinence, new pressure ulcers, and increased
rate of nosocomial infections.66;67 Severe or permanent injuries include brachial plexus nerve
injuries from wrist restraints, joint contractures, and hypoxic encephalopathy. The most serious
injury is death from strangulation.34 Although most data about the adverse consequences of
physical restraints is from non-ICU settings, in the ICU agitation is common and consequences
of uncontrolled agitation are more dangerous (removal of critical lines and catheters) than
potential lethal results of device removal. Use of techniques that reduce the likelihood of risk
and the use of non-physical interventions is recommended.33;68
Evaluation of agitation
Currently there is no gold standard to alert health care providers to impending agitation,
although scales exist to evaluate patient state/degree of agitation once agitation has been

31

identified. Most scales currently in use have the same inherent issues – many agitation levels
have overlapping criteria and rely on the subjective evaluation of the patient’s state. Both have
the potential to contribute to inconsistent scoring or identification of the degree of agitation.
Despite these shortcomings, systematic evaluation of agitation and pain with rapid-response
treatment shows promise in decreasing agitation events. In a study in 2006 by Chanques et
al.,69 an education program for nurses and physicians followed by systematic evaluation of pain
and agitation levels by nurses with rapid calls to physicians for treatment decreased the
observed incidence and intensity of pain and agitation in ICU patients. The improved pain and
agitation management was also associated with a significantly shorter duration of mechanical
ventilation (120 vs. 65 hrs., p = .01) and lower nosocomial infection rate (17% vs. 8%, p < .05).
At present there are no clinically useful, valid and reliable tools for the objective
measurement of agitation; however, there are promising avenues of exploration.
Subjective measures of agitation.
Adult subjective sedation-agitation scales are used by healthcare providers to determine the
patient's level of sedation and agitation.70;71 Recommendations for the use of a validated
sedation assessment scale5 and a need for prospective studies to establish and study
population-specific, goal-oriented sedation-agitation scales to enhance the consistency of
caregiver observations and allow comparison of drug effects in adults72 have been documented
by both national physician and nurse organizations. Although a variety of scales measure
sedation, many of these do not also evaluate agitation. Some pain scales such as the Adult
Nonverbal Pain Scale (NVPS)73 (patterned after the face, legs, activity, cry, consolability, and
pain assessment tool [FLACC]) and the Critical Care Pain Observation Tool (CPOT)74 include a
movement component (as body movement is considered indicative of pain) but do not
specifically rate agitation.
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The most common and widely used scales measuring agitation in adult ICUs have been
well-reviewed in other articles. This review will briefly describe widely used tools that have had
studies establishing validity and reliability with a focus specifically on agitation.
The Ramsay Scale.75 This is one of the first scales designed for evaluating the level of
consciousness during sedation in ICU patients and is still commonly used today. The 6-point
scale includes one agitation response option of “patient anxious or agitated or both” (given an
assessment value of 1). The tool would be less useful for identification of agitation per se as
“anxious”, a patient state, is not generally accepted to be synonymous with “agitated”, a patient
behavior – the category would not be considered discrete.
The Riker Sedation-Agitation Scale (SAS).7 The SAS was designed to assess agitation and
sedation in adult ICU patients. This tool is a 7 point scale with 3 severity levels for agitation:
“Agitated”, “Very agitated”, and “Dangerous agitation”. It fulfills some of the criteria for a
desirable tool: it was developed from multidisciplinary involvement (nursing, medicine, and
clinical pharmacology); it has applicability to diverse ICU patient populations; it is easy to use;
each level has multiple patient behavior descriptors; the levels may guide sedation
administration; and it has been tested for reliability7 (r=0.91, p<0.001, weighted kappa 0.92,
p<0.001; r=0.98) and validity7 (validity vs Ramsay scale: r=0.91, p<0.001; validity vs Harris
scale: r=0.93, p<0.001).
A potential weakness of this tool is a lack of “specific and discrete criteria for each level”. As
a previously mentioned problem with the Ramsay Scale, “anxious” is not a specific descriptor for
the SAS diagnosis “agitated” (level 5). Considering distinction of criteria, judicious use of
physical restraints (in level 6, “Very agitated”) at the discretion of the caregiver, may be chosen
when the patient begins pulling at the endotracheal tube (in level 7, “Dangerous agitation”);
likewise, biting the endotracheal tube (in level 6, “Very agitated”) may occur when the patient is
attempting to sit up (in level 5, “Agitated”). The categories are not mutually exclusive.
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The Richmond Agitation Sedation Scale (RASS).8 The RASS was designed for assessing
sedation and agitation in adult ICU patients. This instrument is a 10 point scale with one level
for “Restless” (+1) and 3 levels for agitation: “Agitated” (+2), “Very agitated” (+3), and
“Combative” (+4). Similar to the SAS, it fulfills criteria for a desirable tool: developed from
multidisciplinary involvement (nursing, medicine, and clinical pharmacology), used in diverse
patient populations, easy to use, each level has multiple patient behavior descriptors, levels
may guide sedation administration, and extensively tested for validity (against the Ramsay
[r= -0.78]8 and SAS [r=0.78],8 and against the BIS [r=0.63],76 and actigraphy [r=0.58]77) and
reliability (r=0.956; K=0.73 for 5 raters; r=0.964, K=0.80 for nurse educator vs. 27 RNs).8
This scale provides greater discrimination between levels of agitation with a total of four
categories, versus the SAS’s three. The RASS assigns the term “Restless” (+1) as behavior
indicative of the patient states of anxiety and apprehension (rather than designate it as
“agitation” in the SAS), enhancing specificity. The instrument is easy to administer, recall, and
interpret and descriptors are concise. Similar to the SAS, however, is the issue of distinct levels
– “Movements not aggressive or vigorous” (Score +1, “Restless”) are not mutually exclusive of
“Frequent nonpurposeful movement” (Score +2, “Agitated”). In general, however, this
instrument can be considered one of the best for evaluation of agitation.
Adaptation to Intensive Care Environment (ATICE).78 This instrument includes multiple
domains for consciousness (with subscales for awakeness and comprehension) and tolerance
(with subscales for calmness [agitation], ventilator synchrony, and face relaxation) in evaluating
mechanically ventilated adult ICU patients. Low ATICE scores reflect poor adaptation to the
ICU environment (altered consciousness, eyes closed, agitation, permanent grimacing);
likewise, high scores indicate good adaptation (eyes opening spontaneously, calmness,
comprehension, relaxed face). The ATICE was developed from multidisciplinary involvement
(nursing and medicine), is easy to use, and was tested for validity (cross-sectional and
longitudinal confirmed by strong correlations between ATICE and relevant items/domains of the
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Ramsay Scale, Riker Scale, Glasgow Coma Scale, Comfort Scale, visual analog scales, and
amounts of sedatives and analgesics administered) and reliability (high interrater reliability
indicated by high intraclass correlation coefficients [from 0.92 to 0.99]).
It should be recognized that the ATICE was designed to measure adaptation to the ICU
environment; the calmness subscore was not intended to be used as a single tool to evaluate
agitation. Calmness grading is easily understood; however, use of both a summated scale and
Likert scale for ATICE evaluations may be confusing to some. Three levels of agitation rating
are used (similar to the SAS), evaluated on a scale from 2 “agitation, responds to verbal order”
through 0 “life-threatening agitation”. An agitation subscale weakness includes specificity: “life
threatening agitation” (0) is not mutually exclusive of “agitation, does not respond to verbal
order” (2). Of note is that there are 20 separate steps involved in performing a full ATICE
assessment. This tool also lacks applicability to diverse ICU patient populations as it was
designed specifically for use in the mechanically ventilated patient.
Objective measures of agitation.
As agitation is associated with excessive restlessness and physical activity, the ability to
objectively detect increasing activity, especially continuously, may be an important first step in
assessing impending agitation. There are promising directions of inquiry:
Actigraphy. The electronic device, the actigraph, strapped to the wrist or ankle, provides a
continuous measure of activity data (expressions of accelerated movement in numerical form)
and can continuously sense and record minimal movements. The use of actigraphy as an
objective measure of movement has been tested and shows promise;77 however, at this time,
actigraphy has not been fully validated as an appropriate or sensitive measure of agitation.
Heart rate variability (HRV), blood pressure variability (BPV), and systolic BP. Chase et al.79
investigated decreased heart rate variability (HRV), increased blood pressure variability (BPV),
and increased systolic BP (processed by wavelet transforms and autoregressive signal
processing) as an objective measure of agitation in 13 normal subjects and 5 ICU patients. The
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detected agitation levels showed good correlation with agitation levels provided by trained
nursing staff using the modified Riker Sedation-Agitation Scale (SAS).7 At present this process
is not clinically feasible; future studies are required to validate the process on a larger sample.
Unoki et al.80 studied HRV as a marker of the function of the autonomic nervous system in
patients receiving MV, and concluded that deep sedation may be associated with depression of
parasympathetic function. Future studies are required to establish HRV as an indicator of stress
or agitation.
Digitalized images. Facial grimacing and full body movement (as recorded digitalized
images) were explored in the context of correlation with agitation by Becouze et al.81 These
methods require further testing and clinical validation; however, they may be useful in the future.
Future directions for research related to agitation
There has been a paucity of research involving agitation; therefore a great number of
possibilities for exploration exist:


The clinical presentation of agitation should be investigated systematically and terms used
to describe agitation should be standardized.
o

A gold-standard tool for the identification and evaluation of agitation is needed.
Currently, the RASS8 has a greater number and more discrete levels of agitation
than other scales but a consensus is essential for standardization. This would serve
to reduce confounding variables related to construct and criterion validity.



The selection of any of the numerous suspected causative factors of agitation could be
studied with correlation to agitation.



Using greater sample sizes in future studies may assist in clarifying factors.



One proposed etiology of agitation is enzymatic alteration from a wide variety of
physiological and chemical insults resulting in dysregulation of neurotransmitters.
Comparisons of neurotransmitter differences between agitated and calm patients may
suggest which of these could be responsible.
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Animal studies could be initiated to probe the pathophysiological mechanisms of agitation.



Greater levels of severity of illness have been associated with agitation. Determining the
specific level or level range significantly associated with the onset may be key to targeting
patients for both inclusion in studies and for proposed interventions.

In summary, a critical barrier to progress in solving the problem of agitation has been the
lack of empirical identification of the precursors of agitation which, with the appropriate
intervention, could eliminate the need to treat the agitated patient. Use of empirically-based
information would assist care providers in identifying those at risk as well as predict agitation.
After identification of the risk factors and predictors, an evaluative tool could be developed to
alert caretakers to the possibility of agitation – interventions could be implemented well before
agitation occurs. Elimination or reduction of agitation in the ICU would significantly improve
patient safety, and reduce hospitalization resulting in significant savings to healthcare costs.
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ABSTRACT

Background: Agitation in critically ill adults is a frequent complication of hospitalization and
can result in life-threatening complications to the patient or care providers, and has been found
to extend the hospital length of stay thereby increasing hospital costs.
Objectives: The specific aim of this study was to describe the incidence, onset, and temporal
factors related to agitation.
Methods: The sample included all adult patients, consecutively admitted to a medical ICU
(MICU) and surgical trauma ICU (STICU), over a two month period. Data were collected during
the first 5 days of ICU stay. Agitation was identified using the documented Richmond AgitationSedation Scale or notation of “agitation” in the medical record. The hour was used as the
documentation epoch and data were summarized by hour, 4-hour block, and day for each
subject.
Results: 200 subjects were enrolled, 100 from each ICU. 118 (59%) were agitated at any time
during the 5 days. The over-all agitation rate was 7.8% of the hourly. Agitation onset was a
mean of 11.6 hours from ICU admission. Of those subjects who were agitated at any time
during the study, 86% (n=102) had agitation on day 1. Subjects in the MRICU had a significantly
greater number of agitation hours in the first day and first hour of admission and also
significantly earlier agitation onset.
Conclusions: Agitation is present in over one-half of ICU patients, typically develops on the
first day in the ICU stay, and involves consecutive days. It occurs earlier in medical ICUs.
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Agitation is excessive restlessness, or non-purposeful physical activity associated with
internal tension, anxiety, or emotional distress.1-3 These behaviors may include both
nonaggressive and aggressive physical components (i.e. aimless psychomotor activity vs.
physical altercation/hostility) and verbal components (i.e. persistent questioning, chatting vs.
cursing, screaming). Up to 71% of Intensive Care Unit (ICU) patients have some degree of
agitation during their ICU stay.4 Agitation has been shown to extend the length of hospital stay
from a median of 5 to 12 days contributing to increased costs and is associated with adverse
clinical outcomes.5;6 Agitation can be manifested in simple apprehension or anxiety,
inappropriate self-removal of indwelling tubes and catheters, and/or to attempted assault of a
care provider.7;8
The Society of Critical Care Medicine’s (SCCM) recent sedation and analgesia
guidelines now also include agitation, and highlight the need for prompt identification and
treatment of possible underlying causes of agitation.9 Understanding the natural history of
agitation may be important for agitation management as the identification of agitation before it is
manifested may reduce its adverse effects. Knowledge of agitation onset and course may
provide information about timing to encourage enhanced vigilance so interventions can be
implemented to prevent or ameliorate the phenomena and its consequences. Early
identification of patients at risk may lead to reduction in adverse outcomes and cost associated
with sedation and hospitalization. Although agitation is associated with deleterious outcomes,
there are few data that describe the frequency, onset, and course of agitation in the critical care
environment. Therefore, the specific aim of this study was to describe the frequency, onset and
patterns of agitation in the adult critically ill population.
METHODS
Subjects and Setting
The study was conducted in an 865-bed academic medical center which offers a wide
range of patient care services including all critical care specialties. Approval was obtained from
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the Institutional Review Board of the university. The study was conducted in 2 adult units
(medical-respiratory ICU [MRICU] and surgical trauma ICU [STICU]). The sample included all
adult patients, 18 years of age and older, consecutively admitted to the MRICU and STICU over
a two month period using a retrospective medical record review. Patient exclusion criteria were
an ICU length of stay less than 24 hours (to omit those who had a short length of ICU for
overnight monitoring), those with medical records that were not available, and patients
previously admitted during the study duration. Other exclusion criteria were conditions affecting
patient movement interfering with sedation scale scoring including administration of paralytics
preventing any movement, patients with chronic, persistent neuro-muscular disorders (such as
cerebral palsy and Parkinson’s disease), and patients with head trauma or stroke.
Documentation of Agitation
Agitation was identified using the documented Richmond Agitation-Sedation Scale
(RASS), a 10 point scale, from +4 (combative) through 0 (calm, alert) to -5 (unarousable)
assessed at the bedside in 3 steps using discreet criteria, over 30-60 seconds8 (Table 1). The
new 2013 SCCM guidelines endorse the RASS as one of the most valid and reliable sedation
assessment tools for measuring quality and depth of sedation in adult ICU patients.9 The RASS
has demonstrated excellent interrater reliability and criterion, construct, and face validity across
a variety of critical care settings.8;10-12 The RASS is the standard sedation-agitation tool used in
both of the target ICUs. RASS values are routinely obtained every 4 hours in the units and more
frequently if needed. A RASS of +1 (restless – anxious or apprehensive but movements not
aggressive or vigorous) through +4 (combative – overtly combative or violent; immediate danger
to staff) were used to identify agitation. The +1 RASS was accepted as an indicator for agitation
as it indicates restlessness, anxiety, or apprehension – qualities not present in a calm and alert
patient (RASS = 0) and use of positive numbers in the RASS have been previously documented
as agitation.8
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Table 1. The Richmond Agitation-Sedation Scale
Score

Term

Description

+4

Combative

Overtly combative or violent; immediate danger to staff

+3

Very agitated

Pulls on or removes tube(s) or catheter(s) or has aggressive behavior toward staff

+2

Agitated

Frequent non-purposeful movement or patient–ventilator dyssynchrony

+1

Restless

Anxious or apprehensive but movements not aggressive or vigorous

0

Alert and calm

−1

Drowsy

Not fully alert, but has sustained (more than 10 seconds) awakening, with eye
contact, to voice

−2

Light sedation

Briefly (less than 10 seconds) awakens with eye contact to voice

−3

Moderate sedation

Any movement (but no eye contact) to voice

−4

Deep sedation

No response to voice, but any movement to physical stimulation

−5

Unarousable

No response to voice or physical stimulation

Agitation was also documented using the keyword “agitation” (all forms of the word,
“agitated”, “agitation”, “agit”) recorded from the medical record using physicians’ and nurses’
notes in the nursing bedside flowsheet, emergency department documentation, operating room
notes, and circle-the-item for reporting agitation in flowsheets.
Procedure
The medical record was used as the primary source of information and data collection
was conducted by a single investigator (RSB). A pilot study was performed, using subjects not
part of the study cohort, to systematize data collection and to identify and resolve any
ambiguous or conflicting data. Data audits were performed to verify accuracy of information
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using convenience sampling on approximately 10% of all subjects. The error rate on the data
audit was less than 0.03%.
Once admission patterns had been identified our goal was to obtain an equal number of
subjects in each unit that would span the majority of the two month period, so that a broad
representation of unit admissions would be obtained. Data were collected during the first 5 days
of ICU stay as agitation onset and duration has been shown to be 3 to 5 days.4;6 All data were
de-identified and patients were assigned a subject ID number.
For all recurrent data collection, the hour was used as the documentation epoch. Each
individual hour was documented as an agitation hour only if the RASS was +1 or above, or the
word agitation (or its forms) was found in the medical record during that hour. If any agitation
was documented within the hour or there were multiple documented agitation episodes it was
considered to be one agitation hour. Subject demographics were also recorded (age, gender,
ethnicity, race) as well as admission source (clinic, ED, home, long term care, or outside
hospital), admission diagnosis, intubation status, severity of illness score obtained on admission
to the ICU using the Acute Physiology And Chronic Health Evaluation III (APACHE III),13
Charlson Comorbidity Index,14 ICU length of stay (LOS), hospital LOS, and administration of
analgesics and sedatives.
Data Analysis
Data were summarized by hour, 4-hour block, and day for each subject and categorized
as an agitation or non-agitation hour, block, or day. Hourly data were condensed into 4-hour
blocks as the standard ICU flowsheet contained 4-hour blocks with “agitation” available as a
circle-the-item. If any agitation was documented within the 4-hour block or there were multiple
documented agitation episodes it was considered to be one agitation block. This consolidation
of hours reduced documentation redundancy error while smoothing data peaks. In addition data
hours were also condensed into 24-hour periods (“per day”). If any agitation was documented
within the 24-hour period it was considered to be one agitation day. Additional data collection
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included time, ICU day, day of the week, all RASS values, as well as other descriptors of
agitated and abnormal behavior. Percent of agitation hours, blocks and days were based on the
number of these divided by the number of observed hours, blocks and days throughout the 5
day period, as the number of observed hours, blocks and days varied based on the subject’s
duration of ICU stay. Agitation reported as “any time” included documentation of any agitation at
any time during the study period. For agitation onset data, only the first agitation hour, block,
and day for each subject during the study period was evaluated. To investigate agitation
temporal patterns, all agitation blocks were grouped by day of the week, day/night intervals, and
time of day.
Descriptive data were expressed as counts and percentages for all nominal and
categorical data, and mean, range, and standard deviation (SD) for continuous measures.
Univariate analyses were performed between non-agitated and agitated subjects using X2 and
Fisher’s Exact Test for categorical data, and Two Sample t Test for continuous data.
RESULTS
Subjects
Over the two month data collection period, 383 potential subjects were reviewed
resulting in 200 subjects who qualified by applying inclusion and exclusion criteria and were
used for analysis (Figure 1). Medical record review for up to 5 days of ICU stay for the 200
subjects resulted in 791 patient-days (17,938 hours of data; 4,621 4-hour blocks). Subjects had
an average length of ICU stay of 7.9 days (Table 2).
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Figure 1. Flow diagram of study selection process
Total patients screened
N = 383

MRICU
Screened
N = 179

MRICU: Did not meet inclusion criteria
N = 79
56
8
9
6

In unit < 24 hours
Neuromuscular disorder/paralysis
Head trauma/obtunded
Readmission

STICU
Screened
N = 204

STICU: Did not meet inclusion criteria
N = 104
82
5
4
12
1

MRICU subjects used in final
analysis
N = 100

In unit < 24 hours
Neuromuscular disorder/paralysis
Head trauma/obtunded
Readmission
Medical record not available

STICU subjects used in final analysis
N = 100
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Table 2. Demographics and other descriptors for entire sample and by presence of
agitation (at least one observation of agitation per hour)

Entire sample
n = 200
n (%)

Non-agitated Pts
n = 82 (41%)
n (%)

Agitated Pts
n = 118 (59%)
n (%)

Male

113 (56.5)

42 (51)

73 (62)

Female

87 (43.5)

40 (49)

45 (38)

Hispanic or Latino

6 (3)

5 (6)

1 (1)

Not Hispanic or Latino

194 (97)

77 (94)

117 (99)

Asian
Black or African American

3 (1.5)
94 (47)

2 (2)
39 (48)

1 (1)
55 (47)

White

103 (51.5)

41 (50)

62 (53)

100 (50)
100 (50)

36 (44)
46 (56)

64 (54)
54 (46)

Long term care

3 (1.5)

2 (1)

1 (0.5)

Home

16 (8)

4 (2)

12 (6)

Clinic

20 (10)

7 (3.5)

13 (6.5)

Outside hospital

60 (30)

23 (11.5)

37 (18.5)

ED

101 (50.5)

46 (23)

55 (27.5)

Trauma

36 (18)

18 (22)

18 (15)

Sepsis
Respiratory failure

35 (17.5)
27 (13.5)

17 (21)
6 (7)

18 (15)
21 (18)

Hematologic/oncologic problem

27 (13.5)

8 (10)

20 (17)

Other
Renal/GI problem/DKA

22 (11)
28 (14)

9 (11)
15 (19)

12 (10)
13 (11)

Hepatic problem

13 (6.5)

4 (5)

9 (8)

Cardiovascular problem
Drug overdose/poisoning

8 (4)
4 (2)

4 (5)
1 (1)

4 (3)
3 (3)

Intubated

118 (59)

20 (17)

98 (83)

Variable

Mean (Range, SD)

Mean (Range, SD)

Mean (Range, SD)

Age (years)

55.5 (18-89; +/- 16.4)

56 (19-87; +/- 16.4)

55.1 (18-89; +/- 16.5)

Variable
Gender

Ethnicity

Race

ICU Type
Medical Respiratory ICU
Surgical Trauma ICU
Admission Source

Admitting Diagnosis

ICU length of stay (days)

7.1 (1-99.4; +/- 9.7)

5.9 (1-99.4; +/- 12.1)

7.9 (1.5-36.2; +/- 7.6)

Hospital length of stay (days)

16.6 (1-99.5; +/- 15.3)

15.8 (1-99.5; +/- 16.3)

17.1 (2.2-79; +/- 14.7)

APACHE III score

68 (4-200; +/- 31.9)

57.7 (4-200; +/- 34.3)

74.7 (21-170; +/- 28.2)

SOFA

6.625 (0-18; +/- 3.8)

5.39 (1-17; +/- 3.7)

7.48 (0-18 ; +/- 3.7)

Charlson Comorbidity Index

4.69 (0-17; +/- 3.3)

4.8 (0-13; +/- 3.3)

4.6 (0-17; +/- 3.4)

Abbreviations: patients (pts); intenstive care unit (ICU); emergency department (ED); gastrointestingal (GI); Diabetic
ketoacidosis(DKA); Acute Physiology And Chronic Health Evaluation (APACHE III); Sequential Organ Failure Assessment (SOFA)
Data are presented as number (%), mean +/- SD, or median (25th – 75th percentiles)
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The subjects had a mean age of 55 years and were primarily men, non-Hispanic, and
white or African American (Table 2). Mean APACHE III scores, Charlson Comorbidity Index,
length of ICU stay, hospital length of stay, and admission source are also shown in Table 2;
selected analgesic and sedative medication use is shown in Table 3. During documentation,
terms used to describe agitation and their frequencies were recorded (Table 4). The two
categories “agitation” and “very agitated, acutely agitated, extremely agitated” included only
actual documentation of the keywords indicated. The other categories’ notations were
behavioral and were only recorded if accompanied by an agitation keyword.
Table 3. Analgesic and sedative medications received at any time for total sample over
5-day data collection period
Medication
Analgesics
Fentanyl
Morphine
Hydromorphone
Sedatives
Midazolam
Propofol
Lorazepam
Haloperidol
Diazepam
Dexmedetomidine

Number (%) of pts*
117 (58.5)
83 (41.5)
26 (13)
95 (47.5)
52 (26)
32 (16)
24 (12)
2 (1)
1 (0.5)

*Total is more than 100% as subjects received more than one drug

Table 4. Terms used to describe agitation and their frequencies.
Term
Agitation

Frequency
301

Very agitated, acutely agitated, extremely agitated

18

Confused/disoriented/AMS*

73

Restless/thrashing/moving around in bed*

41

Pulling clinical tubing/endotracheal tube (ETT)/leads and other items*

27

Aggressive/combative*

14

Biting ETT, attempting to tongue out ETT*

11

Agitation w tactile stimulation/suctioning*

9

*With report of agitation keyword and/or RASS of +1 to +4
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Agitation Frequency
Of the 200 subjects, 118 (59%) were agitated at any time during the 5 days during 319
(31.9%) patient-days. Approximately one quarter (28.5 %) of the agitation documentation was
based on RASS with the balance using an agitation keyword.
Of 17,938 total data hours, the overall agitation rate was 7.8% of the hourly time (1389
hours) and 19.1% of the 4-hour block time (883 blocks). Of these 4-hour blocks, 36.2%
occurred on day 1 (n=102), 20.7% on day 2 (n=71), 16.8% on day 3 (n=60), 14.7% on day 4
(n=50), and 11.7% on day 5 (n=36). Considering the total sample of non-agitated and agitated
subjects, percent of agitation was significantly higher on day 1 than other days: 23.3% on day
1, 15.8% on day 2, 16.1% on day 3, 19.3% on day 4, and 20.2% on day 5 (Figure 2).

Figure 2. Percent of time agitated.

Agitation Onset
The onset of agitation was investigated. The onset of agitation was a mean of 11.6
hours (SD 22.3; Range 0-114; IQR 0-13.75) from ICU admission. Of those subjects who were
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agitated at any time during the study, 86% (n=102) had agitation on day 1, the remaining 14%
(n=16) had an agitation onset spread out over the next 4 days (Figure 3).

Figure 3. Number of agitated patients who experienced any agitation per day by agitation
onset day

The majority of subjects (n=102; 86%) with first-day agitation continued to have agitation across
other days, while those with later agitation onset had relatively low agitation frequency. Of the
102 subjects with first-day agitation, 44 (43.1%) had agitation reported on ICU admission; 30
more (another 29.4%) had agitation reported from 1 to 4 hours from ICU admission. The mean
onset of agitation for those who had first-day agitation onset was 3.97 hours from admission
(SD 6.4; Range 0-24; IQR 0-5).

Patterns of Agitation – Onset and Frequency
Patterns of agitation frequency and onset were investigated for day of the week,
day/night intervals, and 4-hour block of day. For day of the week, Tuesdays had the highest
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number of agitation hours (253) with the lowest on Friday (157). Considering only first-time
agitation hours, Monday was highest (26) closely followed by Tuesday (23), with Sunday the
lowest (11). Frequency of agitation during the day (7A-7P) versus the night (7P-7A) showed
almost equal number of hours – day (n=679), night (n=710). First-event agitation hours during
the day were 63 vs. 55 during the night. For 4-hour blocks, the pattern of agitation onset from
8PM to midnight was higher than others (Figure 4).
Figure 4. Agitation hours per 4-hour block

Considering the agitation pattern from a day perspective, of the 118 subjects with
agitation at any time, 88 (74.6%) had multiple days of agitation including both those with
intermittent and consecutive days of agitation (Figure 5). It is notable that the majority of
patterns of consecutive, intermittent, and single day agitation involved day 1 agitation.
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Figure 5. Day patterns of agitation depicting the significant portion of agitation that
occurs on day 1

•
•


o
o

Intermittent agitation – day 1: The percent of total agitation of all patients that had intermittent
agitation on day 1
Intermittent agitation – all other days: The percent of total agitation of all patients that had intermittent
agitation on any day other than day 1
Single day of agitation – day 1: The percent of total agitation of all patients that had a single day of
agitation on day 1
Single day of agitation – all other days: The percent of total agitation of all patients that had a single
day of agitation on any day other than day 1
Consecutive days of agitation – day 1: The percent of total agitation of all patients that had
consecutive days of agitation beginning on day 1
Consecutive days of agitation – all other days: The percent of total agitation of all patients that had
consecutive days of agitation beginning on any day other than day 1

Agitation Patterns by Unit
Unit comparisons were conducted to determine differences in agitation between the
MRICU and STICU subjects. Univariate analyses were performed between non-agitated and
agitated subjects in the two units using X2, Fisher’s Exact Test, and Two Sample Test for
Proportions for categorical data, and Two Sample t Test for continuous data.
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There was no difference between the MRICU and the STICU in subject age, ethnicity,
race, admitting diagnosis, as well as ICU and hospital LOS (Table 5). The MRICU subjects had
a greater number of total documentation hours than the STICU although not different between
the units. The two units were not different in the number of patients with first day, hour or block
agitation. APACHE III, SOFA, and Charlson Comorbidity Index scores on admission to the
ICUs were significantly higher for MRICU subjects than for STICU subjects. Subjects in the
MRICU had a significantly higher percent of agitated patients on day 1 and 2 although there was
no difference between the two units in mean agitation hour onset.
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Table 5. Comparison of agitated patients between MRICU vs. STICU.
Unit
Variable
Total documentation hours
Total agitation hours
Total documentation blocks
Total agitation blocks
*
Agitated patients
Agitation hours in first day of admission
Agitation blocks in first day of admission
Patients agitated in first day of admission
Patients agitated in first hour of admission
Patients agitated in first block of admission

MRICU (n =100)
n (%)
9228 (51.4)
931
2399 (51.9)
560 (23.3)
64 (54)
354
207
57 (89.1)
26 (48.1)
36 (56.3)

STICU (n =100)
n (%)
8710 (48.6)
458
2222 (48.1)
323 (14.5)
54 (46)
139
101
45 (83.3)
18 (33.3)
24 (44.4)

p value

Patient Level Data
Percent agitation by hour
Percent agitation by block
Percent agitation by day
Day 1
Day 2
Day 3
Day 4
Day 5
Mean agitation onset hour from admission
Age (years)
ICU length of stay (days)
Hospital length of stay (days)
APACHE III score on admission to the ICU
SOFA
Charlson Comorbidity Index

Mean (SD)
9.2 (9.5)
21.7 (21.4)

Range
0-43
0-68

Mean (SD)
4.7 (6.8)
12.6 (16.4)

Range
0-29
0-77

p value
<.0001
0.001

31.9 (32.8)
21.4 (26.7)
15.1 (24.2)
12.4 (24.6)
8.9 (20.6)
8.4 (17.2)
56.7 (16.1)
7.9 (7.5)
15.8 (13.1)
81.2 (27.2)
7.6 (3.9)
5.5 (3.3)

0-100
0-100
0-100
0-100
0-83
0-85
18-89
1.5-36.2
2.2-66.8
23-170
0-18
0-17

15.4 (21.6)
9.2 (19.6)
10.3 (24.8)
9.5 (19.9)
8.5 (22.9)
15.5 (26.9)
53.3 (16.8)
7.9 (7.9)
18.6 (16.3)
66.9 (27.7)
5.6 (3.5)
3.8 (3.1)

0-100
0-100
0-100
0-83
0-100
0-114
18-82
1.7-34.1
2.8-78.9
21-132
1-16
0-13

<.0001
0.0003
0.17
0.36
0.88
0.09
0.27
0.97
0.31
0.0056
<.0001
0.0084

0.20

0.12
0.23
0.09

Abbreviations: intensive care unit (ICU); Acute Physiology And Chronic Health Evaluation (APACHE III); Sequential Organ Failure
Assessment (SOFA)

DISCUSSION
Agitation Frequency
Agitation is common in the critically ill. In this study the majority of the sample (59%)
was agitated at any time during the first 5 days of their ICU stay. Our high frequency of
agitation is generally similar to previous studies’ agitation rates. Jaber et al.6 studied 182
medical-surgical ICU subjects over 8 months and found an agitation frequency of 52%. Despite
differences in inclusion criteria (our study excluded patients in the unit less than 24 hours and
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Jaber’s did not) and identification of agitation (our RASS and keyword use vs. Ramsay score),
the frequency of agitation was similar. Gardner et al.4 studied 83 medical respiratory ICU
patients over a 2-month period and found an agitation frequency of 42% using nursing
documentation to rate the level of agitation. Although the study had a smaller sample, they also
used a 2 month period with similar agitation rates. Fraser et al.15 studied 130 medical and
surgical ICU patients over a 4 month period and found an agitation frequency of 70.8%. Their
exclusion criteria were similar to ours; however, their identification of agitation differed and may
explain their higher agitation frequency. They used medical record narratives describing
agitated behavior to quantify agitation using the Sedation Agitation Scale (SAS), identifying
agitation with SAS scores of 5-7 (“agitated”, “very agitated”, and “dangerously agitated”). The
SAS 5 description includes “anxious”, a descriptor not used as indicative of agitation in our
study. Interestingly, using SAS 6 or 7 only, they reported an any-day agitation frequency of
46.1% – similar to what we report here. Woods et al.5 studied 143 medical ICU patients over a
5 month period and reported any-day agitation of 16.1%. This may be explained by the
differences in inclusion criteria (ventilated patients, medical ICU, severity and definition of
agitation) as well as the use of a sedative/analgesic protocol.
There were also similar findings between this study and others regarding patient-days of
agitation. Ours (31.9%) were generally similar those of Gardner et al.’s4 32% and Fraser et
al.’s15 46.1% to 54%. These findings of generally similar agitation frequency suggest that
agitation is consistently pervasive. Our hourly and block agitation rates are unique in that this
level of detail has not been found previously in the literature. The higher rates of block-time
may be due to variations in documentation but may also be more accurate due to the ability of
documentation at the end of the 4-hour block. Agitation is generally not a quickly resolving
issue and the use of the circle-the-item for a 4-hour block may have been used as an efficient
indicator. However, due to individual documentation variation in healthcare providers, the perday agitation rates may allow a more consistent comparison between studies.
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Agitation Onset
We found the onset of agitation occurs early in the ICU stay. This is generally consistent
with the literature. The vast majority of our sample had agitation onset very early the first day of
their ICU stay – considerably earlier than found in previous studies. Fraser et al.15 found the
mean onset time from ICU admission to maximum agitation to be 2.4 days. The differences
may be due to definition of agitation onset. We computed the mean of all subjects’ agitation
onset hours while Fraser reported hours to maximum agitation – however no description of the
method for determining maximum agitation was included. Jaber et al.6 found agitation onset to
be 4.4 ± 5.6 days, more than four times longer; however they stated that most of the patients
became agitated in less than 3 to 5 days. Their data describe early onset of agitation from
several aspects: cumulative distributions of onset and duration of agitation, correlation between
duration of agitation and onset of agitation, and correlation between duration of stay in the ICU
and duration of agitation.
The causes of such early agitation trends remain unclear. Early agitation onset findings
in studies has been thought to be linked to sedative use as the majority of agitated subjects
received sedatives. Use of sedatives has been associated with agitation in several studies;5;6;15
more studies are needed to determine if or what dose of sedative use precipitates agitation or is
involved in neurotransmitter imbalance. Severity of disease has also been suggested to be
associated with early agitation onset. This appears unlikely as, although we used the APACHE
III rather than APACHE II or SAPS, our scores are generally comparable to other studies.5;6;15
First-day agitation is common in the critically ill. We found significantly higher first-day
rates (86%) compared to Woods et al.5 who found 7%. This difference may be attributed
partially to the dissimilar populations and outcome measurement discussed earlier. Interestingly
their subjects actually had higher sedative use (75% - 96%) than ours which seems to contradict
the premise of sedative use as a factor influencing this study’s increased agitation. In addition
to very high first-day agitation rates, over half of our sample had identified agitation in the first
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hour of ICU admission. This suggests that subjects were admitted in an agitated state –
different from other studies. It is unclear to what this can be attributed. The admission source
and location might be thought to influence this finding but no statistical significance or trend was
found.
Patterns of Agitation – Onset and Frequency
The hourly patterns of agitation onset and frequency for day of the week, day/night, or 4hour block intervals were similar. Anecdotally, agitation has been thought to occur more
frequently during the evening/night hours. We found agitation frequency to be higher in the day.
Jaber et al.’s6 study did not find a significant difference in day/night agitation. These results
suggest that agitation is heterogeneous with little diurnal fluctuation.
Agitation patterns over time revealed that day 1 agitation is implicated in all trends but
more significantly in consecutive days.
Agitation Patterns by Unit
In comparing the two subject populations (MRICU and STICU) with regard to agitated
patients, our findings did not reach statistical significance; however Jaber et al.6 found agitation
rates higher in medical subjects. Day 1 and 2 percent patient agitation rates found significantly
higher in the MRICU may reflect higher severity of disease. If agitation or acute brain
dysfunction is a result of dysregulation of neurotransmitters, medical ICU patients may have
greater comorbidities and severity of disease that may contribute to the higher agitation rate and
earlier onset. In support of this supposition, we found the APACHE III and SOFA scores, as
well as the Charlson index significantly higher in the MRICU subjects; Jaber and colleagues6
also found a significantly higher Simplified Acute Physiology Score (SAPS) II in medical
subjects.
Limitations of this study warrant mention. As this was a retrospective chart review,
findings are dependent on data completeness and quality – the data was not originally recorded
for research purposes and may lack in quantity and quality. In an effort to mitigate some of
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these disadvantages, we used a more stringent definition of agitation – documentation of the
word “agitation” or the RASS tool – not relying solely on behavioral cues. Strengths of
retrospective reviews exist: they are reflective of usual care and allow investigators to examine
processes and outcomes as they occur, void of the Hawthorne effect, and they monitor in real
time integrating multiple data sources. We currently lack a continuous method of measuring
agitation over time. Without this, the best alternative is hourly documentation. Differences in
unit samples could be due to differences in unit documentation norms.
Regardless of the evaluation of agitation, whether frequency, onset, or pattern, our data
show agitation in the critically ill is a very early phenomenon involving consecutive days. These
findings have clinical and resource allocation implications. Focusing efforts, resources and
implementing protocols very early in the ICU stay (or before) may prevent the poor outcomes
and dangerous sequellae of agitation as well as reduce ICU costs. In addition, interrupting the
trend of consecutive days of agitation may have an equal impact in lowering overall agitation
frequency.
CONCLUSION
Agitation affects over half of ICU patients, largely occurs the first day in the ICU stay,
and involves consecutive days. Patients in the MRICU have a higher severity of illness than the
STICU and have higher day 1 and 2 rates of patient agitation. Other studies are needed to
clarify patient risk factors and identify strategies (both pharmacological and
nonpharmacological) to prevent, ameliorate, or treat the condition.
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Abstract

Background:
Agitation in critically ill adults is a frequent complication of hospitalization resulting in multiple
adverse outcomes. Studies show from 42-71% of critically ill patients experience agitation and
agitation is observed in up to 32% of patient days.

Objectives:
Potential causes of agitation in critically ill patients are numerous; however, data about factors
that predict agitation are limited. The purpose of this study is to identify predictors of agitation
by investigating demographic and clinical characteristics of critically ill patients.
Methods:
A retrospective medical record review was performed identifying agitation using the Richmond
Agitation-Sedation Scale or the use of an “agitation” keyword. A total of 200 patients were
studied from a medical and surgical ICU. Two models were examined: 1) on admission and 2)
24 hours prior to the first agitation event. Data pertaining to baseline demographics and
preadmission risk factors as well as clinical data were collected and evaluated by logistic
multivariable regression to determine predictors of agitation.
Results:
Predictors of agitation on admission to the ICU were: past medical history of illicit substance
use, height, both the Sequential Organ Failure Assessment (SOFA) respiratory and central
nervous system subscores, and use of restraints. Predictors of agitation identified from data
gathered within 24 hours prior to agitation were: past medical history of psychiatric diagnosis,
height, SOFA score, P/F<200mmHg, serum pH, percent of hours using restraints, percent of
hours using mechanical ventilation, pain, and presence of genitourinary catheters.
Conclusions:
In this study predictors of agitation on admission and within 24 hours prior to agitation onset
were primarily clinical variables. This allows considerable opportunity for intervention to
ameliorate or prevent agitation.
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One of the more frequent complications in the intensive care unit (ICU) is agitation.
Agitation is associated with adverse clinical outcomes: longer ICU stay, longer duration of
mechanical ventilation, a higher rate of self-extubation, unplanned catheter removal, excessive
sedation, increased utilization of resources, and increased ICU costs.1-3 Studies show that from
42-71% of critically ill patients experience agitation.2-5 Recognizing the impact of agitation, The
Society of Critical Care Medicine’s (SCCM) recently updated sedation and analgesia guidelines
now also include agitation, indicating the need to focus on this significant issue.6 The guidelines
highlight the need for prompt identification and treatment of possible underlying causes of
agitation and recommend use of an interdisciplinary team to improve patient management.
Potential causes of agitation in critically ill patients are numerous; however, data about
factors that predict agitation are limited. As agitation is often identified after overtly agitated
behavior is observed, a critical barrier to progress in the field has been the lack of identification
of the precursors of agitation. In order to develop an agitation risk profile for critically ill adults,
identification of risk factors on admission and prior to an agitation event is important.
Empirically based information would therefore assist care providers to identify those at risk as
well as predict agitation. Identification of patients at particularly high risk for developing
agitation provides an opportunity to implement preventative strategies to protect patients from
self- and iatrogenic-induced injury. Therefore the purpose of this study was to examine the
relationship of demographic and clinical characteristics of critically ill patients in the
development of agitation.
METHODS
Subjects and Setting
The study was conducted in an 865-bed academic, Level I Trauma Center which offers
all critical care specialties, using two adult units (medical-respiratory ICU [MRICU] and surgical
trauma ICU [STICU]). All adult patients, 18 years of age and older, consecutively admitted to
the MRICU and STICU over a two month period were evaluated for inclusion using a medical
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record review. The MRICU is a 20 bed medical ICU with approximately 1000 yearly admissions
while the STICU is a 24 bed surgical ICU with approximately 1400 yearly admissions. Approval
was obtained from the University/hospital Institutional Review Board. Patient exclusion criteria
were an ICU length of stay (LOS) less than 24 hours in order to exclude those who were
admitted for short-term/overnight monitoring, those with medical records that were not available,
and patients previously admitted during the study duration. Other exclusion criteria were
conditions affecting patient movement interfering with sedation scale scoring including:
administration of paralytics preventing any movement; patients with chronic, persistent
neuromuscular disorders (such as cerebral palsy and Parkinson’s disease); and patients with
head trauma or stroke.
Measures
Agitation
Agitation was identified using medical record documentation of the Richmond AgitationSedation Scale (RASS), which is a 10 point scale, from +4 (combative) through 0 (calm, alert) to
-5 (unarousable) assessed at the bedside in 3 steps using discrete criteria, over a time of 30-60
seconds.7 The SCCM has identified the RASS as one of the most valid and reliable sedation
assessment tools for measuring quality and depth of sedation in adult ICU patients.6 The
RASS has demonstrated excellent interrater reliability and criterion, construct, and face validity
across a variety of critical care settings.7-11 The RASS was the standard sedation-agitation tool
used in both of the target ICUs and at the time of data collection, no delirium tools were
routinely used. RASS values were routinely obtained every 4 hours in the units and more
frequently if needed. A RASS of +1 (restless – anxious or apprehensive but movements not
aggressive or vigorous) through +4 (combative – overtly combative or violent; immediate danger
to staff) were used to identify agitation. The +1 RASS was accepted as an indicator for agitation
as it indicates restlessness, anxiety, or apprehension – qualities not present in a calm and alert
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patient (RASS = 0); use of positive numbers in the RASS have been previously documented as
an agitation scale.7
Agitation was also identified using the keyword “agitation” (all forms of the word,
“agitated”, “agitation”, “agit”) recorded from the medical record using physicians’ and nurses’
notes in the nursing bedside flowsheet, emergency department documentation, operating room
notes, and circle-the-item for reporting agitation in flowsheets.
Predictors of Agitation
Demographics and Preadmission Risk Factors. Information pertaining to baseline
demographics and preadmission risk factors for agitation were retrieved from admission
summaries. Risk factors previously associated with agitation in the critically ill were identified
from the literature as well as from expert consultation. These data, collected on admission to
the ICU, included demographic characteristics (age, gender, ethnicity, race), marital status,
weight, height, Body Mass Index (BMI), hospital admission source (clinic, emergency
department [ED], home, long term care, or outside hospital), ICU admission source (operating
room, general hospital floor, ED, outside hospital), admitting diagnosis category, and severity of
illness data for the Acute Physiology And Chronic Health Evaluation III (APACHE III),12 the
Sequential Organ Failure Assessment (SOFA),13 as well as the Charlson Age-Comorbidity
Index.14 The APACHE III was also collected on the day of the first agitation event; SOFA scores
were collected daily. A past medical history of specific medical issues was also retrieved and
included a history of diabetes, alcohol abuse, illicit substance use, tobacco use, psychiatric
diagnosis, as well as overuse/abuse and prescribed use of psychiatric medications.
Clinical Risk Factors. Measurable clinical factors were also identified from the literature.
Clinical data collected on admission and 24 hours prior to the first agitation event were worst
daily values (defined as most extreme or farthest from the normal laboratory mean value) for:
creatinine, blood urea nitrogen, daily urine output, bilirubin, hematocrit, and glucose, as well as
Glasgow Coma Score (GCS), PaO2, heart rate, mean arterial pressure, respiration rate, FiO2,
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and temperature. Data collected hourly included: pain rating (Numerical Rating Scale), RASS
score, use of restraints and type of restraints, use of mechanical ventilation (MV), total number
of all catheters as well as number and specific category of invasive lines and catheters
(peripherally inserted, centrally inserted, genitourinary [GU], and gastrointestinal [GI]), use of
dialysis, presence of sepsis (using Criteria of Bone15) and nosocomial infections (hospitalacquired pneumonia, by documentation), as well as community-acquired pneumonia (by
documentation). For variables that occurred continuously (e.g. mechanical ventilation, use of
restraints), use was calculated by hourly percent of time used. For acute renal failure the RIFLE
(Risk of renal dysfunction, Injury to the kidney, Failure of kidney function, Loss of kidney
function, and End-stage kidney disease)16 classification system rating was collected. All
laboratory values for the 5 study days for the following blood tests were recorded on the
reporting hour: pH, sodium, potassium, albumin, magnesium, white blood count (WBC), and
hemoglobin.
Clinical Outcomes
To fully describe the sample, data were also collected related to ICU and hospital length of stay
(LOS), discharge destination or outcome (long term care or other facility, home/prior living
arrangement, or death), and adverse events.
Procedure
All data were collected from the medical record by a single investigator (RSB). A pilot
study was performed, using subjects not part of the study cohort, to organize and streamline
data collection and to identify and resolve any ambiguous or conflicting procedure or data. Data
audits were performed to verify accuracy of information using convenience sampling on
approximately 10% of all subjects. The error rate on the data audit was less than 0.03%.
To ensure that a broad representation of unit admissions would be obtained our goal
was to obtain an equal number of subjects in each of the two study units that would span the
majority of a two month period. Data were collected during the first 5 days of ICU stay as
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agitation onset and duration is highest in the first 3 to 5 days.2;4 All data were de-identified and
patients were assigned a subject ID number.
The hour was used as the documentation epoch for all recurrent data collection. The
hour was considered an agitation hour only if the RASS was +1 or above, or the keyword
agitation (or its forms) was found in the medical record during that hour. If any agitation was
documented within the hour or there were multiple documented agitation episodes, it was
considered to be one agitation hour. For each patient only the first admission to the ICU was
included in data collection and analysis. Data collection included ICU location (MRICU or
STICU) and the ICU hour from admission for up to 5 days.
DATA ANALYSIS
Descriptive statistics were computed on patients’ baseline demographic and clinical
variables. Based on the data structure, categorical data was described as number (percent),
normally distributed continuous data was described as mean ± standard deviation, and nonnormal continuous data was described as the median with interquartile range (25th - 75th
percentile). For every subject only the first reported occurrence of agitation during the study
period was examined. Thus, any report of agitation during the five study days was used to
identify two study groups (agitated subjects versus nonagitated subjects). For the GU catheter
variable, subjects had either 0 or 1 catheter so the variable was converted to a nominal (yes/no)
response.
We examined developing two separate models to identify predictors of agitation. The
first model focused on factors on admission to the ICU that might predict agitation. The second
model primarily considered factors within 24 hours prior to the first episode of agitation. The
time period of 24 hours was chosen to capture both slower-responding physiologic changes (i.e.
renal or hematologic indices) as well as those with a more rapid rate (i.e. oxygenation or mental
status indices).
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For both scenarios (factors on admission and factors within 24 hours of first agitation
episode), each potential risk factor was examined univariately in simple logistic models to
determine its relationship to agitation. Here, the response variable was agitated or not agitated.
As a screening tool for risk factors, the alpha level for significance was set to 0.10. Next, logistic
regression models were constructed using all significant variables of the univariate analysis and
then using subsets of the significant variables from the univariate analysis. For each subset
considered, backward elimination was used to select the significant predictors of agitation. In
these models, the alpha level was changed to a 0.05 level of significance. Testing for the
significant parameters was conducted using the Likelihood Ratio (LR). Alternative models were
compared in terms of statistical significance of each predictor, goodness-of-fit statistics (AICc,
BIC and R2 values), and predictive power (e.g. area under the curve [AUC] of the ROC curve
and percent correct classification) in order to determine the best model for predicting agitation
for both scenarios: on admission and within 24 hours prior to the first episode of agitation.
Statistical analysis was performed using SAS JMPvPro10.0 (Cary, NC).
RESULTS
Subjects
Three hundred and eighty three patients, sequentially admitted into the ICUs, were
screened, 179 from the MRICU and 204 from the STICU. There were 79 MRICU subjects not
meeting inclusion criteria: 56 were in the unit less than 24 hours, 8 had neuromuscular
disorders or paralysis, 9 were obtunded or suffered head trauma, and 6 were readmitted. There
were 104 STICU subjects not meeting inclusion criteria: 82 were in the unit less than 24 hours,
5 had neuromuscular disorders or paralysis, 4 were obtunded or suffered head trauma, 12 were
readmitted, and 1 had no medical record available. In all, 200 subjects, 100 from each ICU,
were included in the final analyses. A more detailed, full report of the sample was described in
a companion paper that included agitation onset, frequency, and associated temporal factors.17
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Overall the sample subjects had a mean age of 55 years and were primarily men, nonHispanic, and white or African-American (Table 1). Approximately one quarter (28.5 %) of the
agitation documentation was based on RASS with the balance using an agitation keyword. Of
the 200 subjects, 118 (59%) were agitated at some point over the 5 day study period and
comprised the agitated group for this analysis. Of these 118 agitated subjects, 102 (86%) had
agitation on day 1. Of the 102 that were agitated on day 1, 44 (43%) had agitation reported on
ICU admission.
Predictors of agitation on ICU admission
In the univariate analysis, individual demographic and preadmission factors present on
ICU admission that were significantly associated with agitation were male gender, greater
weight, past medical history of illicit substance use and psychiatric diagnosis (Table 2). Severity
of illness scores associated with agitation were the total SOFA score, the SOFA respiratory and
CNS subscores, the GCS, and APACHE III. Specific clinical factors associated with agitation
were P/F < 200 mmHg, FiO2, serum pH, serum magnesium, serum glucose, use of restraints,
use of MV, pain rating, number of total catheters, presence of GU catheters, and number of GI
and other catheters (Table 2).
Logistic regression analysis showed that the majority of variables remaining in the final
model were clinical factors. The model was statistically significant, indicating that the predictors
as a set reliably distinguished between subjects with and without agitation (chi square = 68.071,
p<.0001 with df = 5). The AUC for the receiver operating characteristic (ROC) was 0.85.
Prediction success overall was 75% (79.3% for subjects with agitation and 69.1% for subjects
without agitation). Predictors of agitation were identified as past medical history of illicit
substance use, height, both the SOFA respiratory and CNS subscores, and use of restraints
(Table 3).
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Table 1. Demographics and other descriptors for entire sample and by presence of
agitation (at least one observation of agitation)

Variable
Gender
Male
Female
Ethnicity
Hispanic or Latino
Not Hispanic or Latino
Race
Asian
Black or African-American
White
ICU Type
Medical Respiratory ICU
Surgical Trauma ICU
Admission Source
Long term care
Home
Clinic
Outside hospital
ED
Admitting Diagnosis
Trauma
Sepsis
Respiratory failure
Hematologic/oncologic problem
Other
Renal/GI problem/DKA
Hepatic problem
Cardiovascular problem
Drug overdose/poisoning
Age (years)
Total ICU length of stay (days)
Total hospital length of stay (days)
APACHE III score
SOFA
Charlson Comorbidity Index

a

Entire sample
n = 200

Non-agitated Pts
n = 82 (41%)

Agitated Pts
n = 118 (59%)

113 (56.5)
87 (43.5)

42 (51)
40 (49)

73 (62)
45 (38)

6 (3)
194 (97)

5 (6)
77 (94)

1 (1)
117 (99)

3 (1.5)
94 (47)
103 (51.5)

2 (2)
39 (48)
41 (50)

1 (1)
55 (47)
62 (53)

100 (50)
100 (50)

36 (44)
46 (56)

64 (54)
54 (46)

3 (1.5)
16 (8)
20 (10)
60 (30)
101 (50.5)

2 (1)
4 (2)
7 (3.5)
23 (11.5)
46 (23)

1 (0.5)
12 (6)
13 (6.5)
37 (18.5)
55 (27.5)

36 (18)
35 (17.5)
27 (13.5)
27 (13.5)
22 (11)
28 (14)
13 (6.5)
8 (4)
4 (2)

18 (22)
17 (21)
6 (7)
8 (10)
9 (11)
15 (19)
4 (5)
4 (5)
1 (1)

18 (15)
18 (15)
21 (18)
20 (17)
12 (10)
13 (11)
9 (8)
4 (3)
3 (3)

55.5 (+/- 16.4)
3.9 (2.5-8)
11.1 (6.3-21.6)
68 (+/- 31.9)
6.625 (+/- 3.8)
4.69 (+/- 3.3)

56 (+/- 16.4)
2.7 (2-8)
9.1 (6-19.4)
57.7 (+/- 34.3)
5.39 (+/- 3.7)
4.8 (+/- 3.3)

55.1 (+/- 16.5)
4.8 (3-9.4)
12.8 (6.9-21.8)
74.7 (+/- 28.2)
7.48 (+/- 3.7)
4.6 (+/- 3.4)

a

At least one documented observation of agitation during the 5-day study time
Abbreviations: patients (pts); intenstive care unit (ICU); emergency department (ED); gastrointestingal (GI); Diabetic
ketoacidosis(DKA); Acute Physiology And Chronic Health Evaluation (APACHE III); Sequential Organ Failure Assessment (SOFA)
Data are presented as number (%), mean +/- SD, or median (25th – 75th percentiles)
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Table 2. Demographic, preadmission and clinical risk factors with univariate significance

Variable
Gender
Male
Female
Height in cm
Weight in kg
Subject PMH
Illicit substance use
Psychiatric diagnosis
Variable
Total SOFA score
Respiratory subscore
CNS subscore
GCS
APACHE III score
Variable
P/F < 200 mmHg
FiO2
Serum pH
Serum magnesium
Serum hemoglobin
Serum glucose
Abnormal Temp ≥ 38
Abnormal Temp ≥ 38, <36
Use of restraints (and percent
of time)
Use of MV (and percent of
time)
Highest pain rating
Total number of catheters
Presence of GU catheters
GI & other catheters

Demographic and Preadmission Risk Factors
At admission
24 hrs prior to onset of Agitation
a
a
Non-agitated
Agitated
Non-agitated
Agitated
42 (51)
40 (49)
167.3 (10.3)
77.1 (22.5)

73 (62)*
45 (38)*
172.1 (10.7)**
83.9 (26.1)*

26 (32)
10 (12)

55 (47)**
28 (24)**
Severity of Illness Scores
At admission
a
Non-agitated
Agitated
6.6 (3.8)
5.4 (3.7)**
0.8 (0.9)
1.3 (1.1)**
1.2 (1.3)
2.5 (1.2)**
12.3 (3.8)
8.6 (3.6)**
57.7 (34.3)
74.7 (28.2)**
Clinical Risk Factors
At admission
a
Non-agitated
Agitated
1 (1)
12 (10)**
0.36 (0.21-0.53) 0.5 (0.4-0.7)**
7.39 (+/- 0.07)
7.36 (+/- 0.095)**
1.89 (+/- 0.32)
1.99 (+/- 0.47)*
10.3 (+/- 2.5)
10.3 (+/- 2.2)
146 (+/- 66)
168 (+/- 84)*
12 (15)
35 (30)**
19 (23)
47 (40)**

-------------

-------------

-------

-------

24 hrs. prior to onset of Agitation
a
Non-agitated
Agitated
5.9 (4.1)
7.4 (3.7)**
0.9 (1)
1.2 (1.1)*
1.3 (1.3)
2.5 (1.1)*
12.3 (3.8)
8.6 (3.6)**
57.7 (34.3)
73.7 (29.3)**
24 hrs. prior to onset of Agitation
a
Non-agitated
Agitated
8 (4)
23 (11.5)*
0.36 (0.21-0.53) 0.5 (0.4-0.7)**
7.39 (+/- 0.09)
7.36 (+/- 0.09)**
1.85 (+/- 0.39)
1.98 (+/- 0.45)*
9.1 (+/- 2.3)
10.1 (+/- 2.2)**
146 (+/- 66)
165 (+/- 84)*
12 (15)
37 (31)**
19 (23)
49 (42)**

6 (7)

40 (34)**

12 (15)

63 (53)**

15 (8)

70 (35)**

18 (9)

80 (40)**

0 (0-5.25)
3.2 (+/- 1.8)
44 (54)
0 (0-1)

0 (0-2.25)**
4.1 (+/- 2.1)**
90 (76)**
1 (0-1)**

6 (2-8.25)
4.1 (+/- 1.9)
52 (63)
1 (0-1)

0 (0-4)**
4.5 (+/- 2)
97 (82)**
1 (0-1.25)

Data are presented as number (%), mean +/- SD, or median (25th – 75th percentiles)
Abbreviations: centimeter (cm); kilogram (kg); MRICU (Medical Respiratory ICU); STICU (Surgical Trauma ICU); past medical
history (PMH); Sequential Organ Failure Assessment (SOFA); central nervous system (CNS); Acute Physiology And Chronic Health
Evaluation (APACHE III); PaO2/FiO2 (P/F); mechanically ventilated (MV); Glasgow Coma Score (GCS); Genitourinary (GU);
Gastrointestinal (GI)
a
At least one documented observation of agitation during the 5-day study time
*p 0.05<.01; **p ≤ 0.05
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Table 3. Predictors of agitation

a

Variable:
On admission to the ICU
Past medical history of illicit substance use
Height
SOFA respiratory subscore
SOFA CNS subscore
Use of restraints
24 hrs prior to onset of first agitation event
Past medical history of psychiatric diagnosis
Height
SOFA score
P/F <200 mmHg
Serum pH
Restraints (1% of time)
Mechanical ventilation (1% of time)
Pain
Presence of GU catheters

Odds ratios

95% CI

LR p value

2.43
1.04
1.58
1.90
3.77

1.18 - 5.15
1.01 – 1.08
1.11 - 2.28
1.45 – 2.54
1.39 - 11.53

0.015
0.016
0.0097
<.0001
0.008

6.24
1.06
2.3
4.7
1.3b
1.04
1.03
1.2
3.8

1.4 – 32.4
1.01 – 1.12
2.1 – 2.6
1.4 – 17.9
1.02b – 1.75b
1.01 – 1.08
1.01 – 1.04
1.05 – 1.4
1.2 – 12.98

0.015
0.015
0.012
0.011
0.026
0.0003
0.0004
0.0059
0.0264

a

At least one observation of agitation during the study time
Abbrev: Sequential Organ Failure Assessment (SOFA); central nervous system (CNS); PaO2/FiO2 (P/F); Likelihood Ratio (LR)
b
for each 0.05 increase in pH

Predictors of agitation within 24 hours prior to agitation
In the univariate analysis, significant individual demographic and preadmission factors
present within 24 hours prior to onset of the first agitation event were the same as the onadmission group (Table 2). Severity of illness scores significantly associated with agitation on
admission were also associated with agitation within 24 hours prior to agitation (SOFA total,
SOFA Respiratory subscore, SOFA CNS subscore, APACHE III total, and GCS) (Table 2). Of
the factors that were significantly associated with agitation on admission, only total number of
catheters, number of GI catheters, and hemoglobin were not significantly associated with
agitation within 24 hours prior to agitation onset (Table 2).
Initially all variables that were significantly associated with agitation were used in the
model describing predictors of agitation within 24 hours of the event. We also evaluated
additional models using subsets of the original variables in order to reduce multicollinearity
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which was generated by constructing models that included more than one measure of severity
of illness (i.e. models considered used only total SOFA, or only SOFA subscores, only total
APACHE III, or only APACHE III subscores). After comparison of these models based upon
AIC, BIC, R2 and ROC and predictive ability, the final model was determined.
Similar to predicting upon admission, logistic regression analysis showed that the
majority of the variables remaining in the model for predicting within 24 hours of the agitation
event were also clinical factors. The model was statistically significant, (chi square = 94.4,
p<.0001 with df = 9) and its associated AUC for the ROC was 0.92. Prediction success overall
was 83% (85% for subjects with agitation and 79% for subjects without agitation). Predictors of
agitation were identified as height, past medical history of psychiatric diagnosis, SOFA score,
P/F < 200, serum pH, percent of hours using restraints, percent of hours using mechanical
ventilation, pain rating, and presence of GU catheters (Table 3). Predictors of agitation similar
for on admission and within 24 hours prior to first agitation event were height and restraints.
Clinical Outcomes
Patient outcomes (length of stay, discharge status and mortality) were also compared
between those who experienced agitation and those who did not. There was no difference
between agitated and nonagitated patients with respect to number of hospital days prior to ICU
admission (p=0.21), ICU length of stay (p=0.12), number of hospital days after ICU discharge
(p=0.89), total hospital length of stay (p=0.56) or in-hospital mortality (19%) (p=0.11).
Discharge destination was significantly different between the two groups (p=.02); non-agitated
subjects were more likely to be discharged to home or prior living arrangement.
Because adverse events are commonly associated with agitation, the number of
documented adverse events (self-removal of tubes or lines, falls, and restraint damage) was
also recorded. In the total sample (n=200), 33 experienced 50 adverse events. In the sample
of 118 agitated subjects, 32 (27%) had 49 adverse events compared to 1 (1%) in 82
nonagitated subjects (p<.0001). Of the 50 adverse events in agitated subjects, 45 (90%) were
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reported concurrent with agitation during the hour, 4 were reported within 2 hours of
documented agitation, and 1 occurred 4 hours from documented intermittent agitation. There
were 28 events in the MRICU and 22 in the STICU. Of the 33 subjects with adverse events, 5
(15%) self-extubated, 3 (9%) pulled out critical catheters or tubes (central line, epidural catheter,
NG tube sutured to nare), 1 (3%) fell out of bed, 1 (3%) tore restraints off, and 30 (91%) pulled
out non-critical catheter/tubes/leads.
DISCUSSION
Agitation is a common and hazardous complication of critical illness. In this study
predictors of agitation on admission and within 24 hours prior to agitation onset were primarily
clinical variables and, except for use of restraints, may represent the severity of the disease
process. Similar to the studies of Fraser et al.3 and Jaber et al.,2 age was not associated with
agitation, although Woods et al.1 found that severely agitated subjects were younger (less than
10 years, p<.04). Agitation was not associated with a longer ICU or hospital stay but was
associated with multiple clinically significant adverse events.
Predictors of agitation on ICU admission
Demographics and Preadmission Risk Factors
Of the preadmission risk factors only past medical history of illicit drug use and height
were predictive of agitation. A record of illicit drug use increased the odds of having agitation
almost 2.5 times, although others have not reported illicit drug use as a predictor of agitation.
Woods1 reported a univariate association with agitation based on marijuana use only, while
Gardner et al.4 evaluated drug and alcohol abuse but did not find them to be a significant
predictor. However, their sample was small (n=83) which may have limited their ability to detect
significance. Alcohol abuse was not associated with agitation; however, Jaber et al.2 reported
that alcohol abuse increased the risk of agitation three-fold. They explained that their study
population may account for this difference as their ICU is associated with the Institute of Liver
and Gastroenterology Disease which treats many alcoholic patients.
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Height predicted agitation but no other study has reported similar results. This was true
on admission as well as for models evaluating 24 hour data prior to agitation and the
explanation for this relationship is unclear. This result is further confounded since factors
associated with height were not predictors, such as weight or body mass index.
Severity of Illness
Although none of the total severity of illness measures predicted agitation, two SOFA
subscores did: respiratory and CNS. The SOFA respiratory subscore uses PaO2/FiO2 mmHg
(P/F); the SOFA CNS subscore is a categorized GCS. The GCS was only significant in the
univariate analysis although it is the basis for the SOFA CNS subscore. The odds of having
agitation increased over 1½ times for every point increase in the SOFA respiratory subscore.
The odds of having agitation increased almost two-fold for every point increase in the SOFA
CNS subscore. Oxygenation level and neurologic condition have been shown to be associated
with agitation.1;4 Impaired oxygenation may result in neurologic deterioration, and the converse
can also be true, in cases where neurologic deterioration leads to inadequate ventilation.
Pulmonary and neurologic subscores of the Multiple Organ Dysfunction Score18 (MODS) also
have been associated with agitation4 – the MODS subscores use the same factors as the SOFA
(P/F and GCS). Therefore patients who have respiratory or neurologic compromise may be at
most risk for agitation on admission.
Clinical Risk Factors
Only use of restraints at admission was predictive of agitation increasing the odds of
having agitation over 3.5 times. Restraint use has been reported in 34% of agitated subjects
and 50% of episodes of agitation.2 Although it is difficult to determine whether restraint use
causes agitation or restraints are used because patients are already agitated, the association of
restraints and agitation is clear. In an observational study by Werner et al.,19 nursing home
residents exhibited either the same amount or more agitated behaviors when they were
restrained than when they were not restrained, suggesting that the act of restraining may itself
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contribute to manifestations of agitation. Werner and colleagues suggest that restriction of
movement, particularly through the use of physical restraints, produces an increase in stress
which may increase agitation.
Predictors of agitation within 24 hours prior to agitation
While we examined data gathered within 24 hours prior to agitation, other investigators
have examined risk factors for agitation at varying time points before the event, including use of
daily data with time-varying covariates1 and data collected within 48 hours prior to agitation1;2
with some comparable predictors. Risk factors for agitation in other studies similar to those in
ours included 1 preadmission risk factor, 1 severity of illness factor, and 3 clinical factors – it is
possible that the large number of first-day agitation could have influenced our findings.
Demographics and Preadmission Risk Factors
Of the preadmission risk factors, height was again predictive of agitation; however, past
medical history of psychiatric diagnosis was identified as a risk factor in this second model.
There was a univariate association with psychiatric diagnosis and agitation on admission but it
was not a predictor in the final model. Our study showed medical history of psychiatric
diagnosis increased the risk of agitation 6 times. In addition to our study, Jaber et al.2 also
described a correlation between psychiatric history and agitation using data collected on regular
use of antipsychotic medications as an indicator of psychiatric disorder. They reported regular
use of psychoactive drugs increased the risk of agitation five times.
Severity of Illness
Increasing severity of illness was a predictor of agitation using the total SOFA score. An
increase in one point on the SOFA score was associated with more than a two-fold increase in
the risk of agitation. An association between agitation and severity of illness was also reported
by Gardner et al.4 They found significantly greater APACHE II scores (23.8 versus 17.5;
p=0.002) as well as MODS (8.2 versus 6.8; p=0.002) on days when subjects were noted to
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exhibit agitated behavior. Jaber et al.2 described a similar severity of illness association but only
in the univariate analysis using the Simplified Acute Physiology Score II.20
Clinical Risk Factors
Use of restraints was associated with agitation both on admission and within 24 hours
prior to the first agitation event. On admission, by definition, we looked at presence of restraints
during one point in time; however, we were able to evaluate percent of restraint use within 24
hours prior to agitation to enhance statistical evaluation. The odds ratio (OR) reported reflected
a 1%-of-the-time use of restraints. Calculating for hourly use, using restraints for only 4 hours
almost doubled the risk of having agitation; using them for 6 hours increased the risk of agitation
over 2.5 times. The use of physical restraints coincides with stress, further aggravating the
already existing neuropathology, which may increase stress and agitation even more.21
However, patient safety is an important consideration when limiting restraint use. All factors
should be weighed carefully before making restraint decisions.
Indicators of oxygenation were risk factors for the onset of agitation on admission and
within 24 hours prior to agitation and included the SOFA respiratory subscore (categorized P/F)
on admission and P/F<200 within 24 hours prior to agitation. A P/F<200 increased the risk of
agitation over 4.5 times. This suggests that severe hypoxemia may contribute to the onset of
agitation.
The amount of time of mechanical ventilation (MV) also predicted agitation. Calculating
for hourly use, using MV for 6 hours almost doubled the OR for agitation; using them for 12
hours increased the risk over 3.5 times, 18 hours over 16 times, and 24 hours over 41 times.
Although guidelines suggest weaning as soon as feasible, MV duration (to support
respiration/oxygenation) is not usually a few hours. Presence of MV in a critically ill patient
should be considered seriously with respect to agitation.
As discussed earlier with the on-admission model, use of MV may be another marker of
oxygenation and neurologic dysfunction, although it is not clear why one of these variables is a
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prediction in the first model and not in the second. Use of MV was not identified in other studies
as a predictor of agitation but is related to other types of respiratory measures that have been
shown to be predictive.1;4 Similar to others,1 acidemia was a risk factor for agitation, which may
also reflect respiratory dysfunction and/or a greater level of illness. Not all investigators have
evaluated pH with respect to the onset of agitation.2;4
The increasing number and types of catheters in the critically ill may certainly lead to
discomfort as well as agitation. Specifically, the presence of a GU catheter increased the
likelihood of having agitation over 3.5 times; GU catheters have also been associated with
agitation in other studies. Yu et al.22 studied postoperative agitation in 2,000 subjects to identify
risk factors. Logistic regression analysis identified presence of a GU catheter to be a predictor
of agitation (p=0.022). GU catheters can be painful;23 it is possible that pain or discomfort may
have been the source for these findings.
Lower pain ratings were associated with agitation – no other study has similar results.
The explanation for this relationship is unclear as the reverse relationship would be expected.
Pain has been shown to be correlated with agitation;24;25 however, measurement of pain,
especially in the critically ill, a population that is often nonverbal, is difficult and valid evaluation
is often elusive.
Clinical Outcomes
There was no difference between the number of hospital days prior to ICU admission,
ICU length of stay, number of hospital days after ICU, and total hospital length of stay in
agitated versus non-agitated patients. Non-agitated patients were more likely to be discharged
home rather than to a long-term care facility. Patients with delirium, including those with both
hyperactive (agitation) and hypoactive delirium, have been shown to have poorer outcomes
including cognitive deficits.26;27 Our overall mean ICU stay (3.9 days) was much shorter than
the ICU length of stay reported by others’ 6 days1;4 and longer.2;3 Other studies have reported
agitation associated with a prolonged ICU stay.1;2 Different findings can be attributed to
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differences in populations, agitation measurement, or differences in clinical trends. Of agitated
ICU patients, we did not find increased in-hospital mortality. Our mortality rate (19%) was
generally similar to others.1-3
Adverse events and rates were similar to other studies. Our unplanned or selfextubation rate (15%) was similar to Jaber2 (17%); however, Woods1 (26%) was higher.
Differences in the sample population and agitation determination could account for the varying
rates.
Overall the majority of predictors of agitation on admission as well as 24 hours prior to
agitation are clinical in nature. This allows considerable opportunity for intervention to
ameliorate or prevent agitation. Current efforts to evaluate need for GU catheters daily and to
remove GU catheters as soon as feasible are recommended to reduce catheter-associated
urinary tract infection risk. There may be an added benefit of reducing agitation. Current
guidelines to reduce ventilator-associated pneumonia encourage backrest elevations greater
than 30°. Backrest elevation may result in decreased patient severity of illness and improved
oxygenation, with the advantage of diminishing agitation. Limiting restraint use for patients,
considered a nurse-sensitive quality indicator by the National Quality Forum,28 improves patient
safety outcomes and may minimize agitation. Using lighter levels of sedation results in
improved clinical outcomes (shorter MV, shorter ICU stay, less PTSD, less depression, more
accurate assessment of patient issues) and may minimize agitation. Current practice initiatives
to gauge readiness for extubation, to facilitate early weaning and shorten ventilator time, may
also result in mitigating agitation.
Limitations of the study are due to the retrospective nature - findings are dependent on
data completeness and quality, and the data were not originally recorded for research purposes.
However, retrospective reviews are also reflective of usual care and allow investigators to
examine processes and outcomes as they occur – they monitor in real time integrating multiple
data sources. In an effort to mitigate some of the disadvantages, we used a more stringent
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definition of agitation – documentation of the word “agitation” or the RASS tool – and used a
larger sample size with good general population representation. Factors associated with
agitation on admission as well as within 24 hours included use of restraints. We are as of yet
unsure what role they play in agitation.
CONCLUSIONS
Agitation is recognized as a serious problem in ICUs. The main findings of this study
were that primarily clinical factors were implicated in the onset of agitation. Agitation was not
associated with a longer ICU stay or hospital stay but was associated with multiple significant
adverse events.
This study contributes new knowledge to the identification of agitation in the medical and
surgical ICU patient populations allowing a better understanding of risk factors of agitation.
Identification of patients at particularly high risk for developing agitation provides an opportunity
to implement preventative strategies to protect patients from self- and iatrogenic-induced injury.
Additional research is needed to identify the cause(s) of agitation, interventional therapies for
prevention, and treatment once agitation has occurred.
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